moxalactam has been researched along with cephalosporin c in 372 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 361 (97.04) | 18.7374 |
1990's | 9 (2.42) | 18.2507 |
2000's | 2 (0.54) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Bauernfeind, A; Eberlein, E; Jungwirth, R; Schweighart, S | 1 |
Kumano, K; Kuroyama, M; Mashimo, S; Sakai, T; Tomonaga, F | 1 |
Baquero, F; Canton, R; Gomez-Alferez, A; Loza, E; Martinez-Beltran, J | 1 |
Ando, A; Kikuchi, S; Minato, K | 1 |
Chimura, T; Saito, H | 1 |
Bies, M; Kessler, RE; Leitner, F; Tsai, YH | 1 |
Adam, D; Naber, K; Schäfer, H | 1 |
Hirauchi, K; Matsubara, T; Uchida, K | 1 |
Gallego, MO; Kerremans, AL; Lipsky, JJ; Van Loon, J; Weinshilboum, RM | 1 |
Duthie, J; Kingston, RD | 1 |
Noel, GJ; Teele, DW | 1 |
Matsubara, T; Mizuno, A; Nakashima, M; Takiguchi, Y; Uchida, K; Uematsu, T | 1 |
Adelman, MH; Grasela, TH; Rigan, D; Schentag, JJ; Welage, LS; Williams, JS; Wilton, JH | 1 |
Heizmann, W; Luft, G; Werner, H | 1 |
Amicosante, G; Frère, JM; Galleni, M | 1 |
Eichenwald, HF | 1 |
Chadwick, EG; Gilmore, R; Kinsella, TR; Shulman, ST; Yogev, R | 1 |
Adelman, MH; Grasela, TH; Schentag, JJ; Welage, LS | 1 |
Haga, T; Miyashita, H; Muraoka, A; Nishiya, H; Nozue, N; Ono, Y; Ueda, Y | 1 |
Graninger, W; Havel, M; Horcher, E; Korninger, H; Kurz, R; Müller, M | 1 |
Hosutt, JA; Lentnek, AL; McDevitt, JT; Nichols, RL; Wikler, MA | 1 |
Hirai, Y; Imamura, K; Kudo, H; Kumasaka, Y; Makino, I; Miyazawa, T; Nakahata, H; Nakamura, T; Takebe, K | 1 |
Eley, A; Greenwood, D | 1 |
Müller, M; Wittmann, DH | 1 |
Duff, P | 1 |
Brister, S; Brown, RA; Chiu, RC; Fradet, G; Mulder, DS; Prentis, J; Richards, GK | 1 |
Bryskier, A; Le Noc, D; Le Noc, P | 2 |
Appel, KR; Lechner, U; Maier, R; Reuter, W; Wetzel, B; Woitun, E | 1 |
Ganzinger, U; Haberl, H; Haslberger, A; Hitzenberger, G; Schatz, F; Schiel, H | 1 |
Ganzinger, U; Haslberger, AG; Millendorfer, A; Reiter, H; Schiel, H | 1 |
Coleman, FH; Dashow, EE; Read, JA | 1 |
Hansman, D | 1 |
Berche, P; Gaillard, JL | 1 |
Inoue, M; Kakizawa, H; Minami, S; Mitsuhashi, S; Saikawa, I; Takai, A; Yasuda, T; Yotsuji, A | 1 |
Daly, JA; Gooch, WM | 1 |
Marsh, TD | 1 |
Bezwoda, WR; Cassel, R; Derman, DP; Perkins, S | 1 |
Bies, M; Buck, RE; Chisholm, DR; Kessler, RE; Leitner, F; Misiek, M; Price, KE; Pursiano, TA; Tsai, YH | 1 |
Barza, M; Noble, JT | 1 |
Hernández, NI; Nevárez, M; Ramírez-Ronda, CH; Rodríguez, JR | 1 |
Andrew, JH; Dixson, S | 1 |
Waldvogel, FA | 1 |
Bakken, JS; Hulsund, M | 1 |
Drusano, GL; Koch, TR; Kroll, MH; Warren, JW | 1 |
File, TM; Salstrom, SJ; Tan, JS | 1 |
Bryskier, A; Labia, R; Morand, A; Verchere-Beaur, C | 1 |
Neu, HC; Prince, AS | 1 |
Maskell, JP; Nasu, M | 1 |
Phillips, GF | 1 |
Ah-See, AK; Anderson, JA; Bennett, B; MacLennan, FM; Wong, AE | 1 |
Lipsky, JJ | 2 |
Buening, MK; Hanasono, GK; Wold, JS | 1 |
Reitan, J; Seeler, RA | 1 |
Leimbrock, C; Pranada, F; Pusztai-Markos, Z | 1 |
Polk, RE | 1 |
Barson, WJ; Nahata, MC | 1 |
Aravind, MK; Kauffman, RE; Miceli, JN | 1 |
Denson, S; Kaplan, SL; Mason, EO; Pickering, LK; Ramos, OM | 1 |
Benonisen, E; Dibb, WL; Digranes, A; Ostervold, B | 1 |
Brier, GL; DeSante, KA; Hatcher, BL; Israel, KS; Wolny, JD | 1 |
Lebas, J; Manuel, C; Meulemans, A; Modai, J; Wolff, M | 1 |
Barza, M; Murphy, TF | 1 |
Aldridge, K; Derks, F; Faro, S; Janney, A; Marier, RL; Sanders, CV; Williams, W | 1 |
Freimer, EH; Gilardi, GL; O'Donnell, ED; Raeder, R | 1 |
Cherubin, CE; Corrado, ML; Landesman, SH | 2 |
Landesman, SH | 1 |
Chiarmonte, DA; Miner, DJ; Schentag, JJ; Ziemniak, JA | 1 |
De Jongh, CA; Finley, RS; Fortner, CL; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH | 1 |
Caparosa, R; Haverkos, HW; Kamerer, D; Yu, VL | 1 |
Cynamon, MH; Granato, PA | 1 |
Aravind, MK; Buckley, JA; Dajani, AS; Kauffman, RE; Kobos, DM; Latif, R; Thirumoorthi, MC | 1 |
Nagata, W; Narisada, M; Ohtani, M; Okada, T; Onoue, H; Yoshida, T | 1 |
Matsumoto, K | 1 |
Chevrel, B | 1 |
Azimi, PH; Dunphy, MG | 1 |
Bouza, E; Burgaleta, C; Martínez-Beltrán, J | 1 |
Finegold, SM; Mathisen, GE; Meyer, RD; Thompson, JM | 1 |
Axelrod, JL; Kochman, RS | 1 |
Daschner, FD; Mählmann, M; Metzger, M; Steffens, A | 1 |
Elenbaas, RM; Harvey, MJ; Klaassen, CD; Robinson, WA; Ryan, JL; Singsank, MJ | 1 |
Baltch, AL; Conroy, JV; Hammer, MC; Smith, RP; Sutphen, NT | 1 |
Mielke, CH; Pakter, RL; Russell, TR; West, D | 1 |
Harada, Y; Nagata, W; Narisada, M; Otsuka, H; Yamada, H; Yoshida, T; Yoshioka, M | 1 |
Barriere, SL; Pons, VG; Wilson, CB | 1 |
Gardner, S; Schreiber, M; Shulman, ST; Yogev, R | 1 |
Feldman, WE; Hollins, M; Keyserling, H; Manning, N; Moffitt, S | 1 |
Marks, MI; Tarpay, MM; Welch, DF | 1 |
Johnson, CE; Pennington, JE; Platt, R | 1 |
Beaucaire, G; Caillaux, M; Deboscker, Y; Fourrier, A; Mouton, Y | 1 |
Brown, KR; Guglielmo, BJ; Jacobs, RA; Pons, VG | 1 |
Carter, MJ; Fisher, JF; Parsons, J; Rissing, JP | 1 |
Brown, JE; Collins, CD; Del Bene, VE | 1 |
Fu, KP; Neu, HC; Srinivasan, S | 1 |
Gentry, LO; Lea, AS; Sudan, AW; Wood, BA | 1 |
Flynn, K; Goldmann, DA; Romagnoli, MF; Siber, GR | 1 |
Black, HR; Brier, GL; DeSante, KA; Israel, KS; Wolny, JD | 1 |
Nelson, TJ; Tosi, MF | 1 |
House, B; Leeds, NH; Peyman, GA | 1 |
Hofstetter, A | 1 |
Bornstein, M; Lo, AY; Thomas, PN; Wilham, WL | 1 |
Bawdon, RE; Cunningham, FG; Quirk, JG; Roark, ML | 1 |
Herbert, DA | 1 |
Konaka, R; Nakamura, M; Sugeno, K; Yamada, H; Yoshida, T | 1 |
Carruthers, M; Cook, FV; Emmerman, J; Phair, JP; Reisberg, BE; Venezio, FR; Westenfelder, GO; Williams, JE | 1 |
Aber, RC; Weitekamp, MR | 1 |
Klastersky, J; Lagast, H; Meunier-Carpentier, F | 1 |
Childs, SJ | 1 |
Panwalker, AP; Rosenfeld, J | 1 |
Fabricius, K; Hey, O; Nix, WA | 1 |
Feigin, RD; Kaplan, SL; Kvernland, SJ; Loiselle, EM; Mason, EO | 1 |
Giger, DK; Goering, RV; Penn, RG; Preheim, LC; Sanders, CC | 1 |
Evans, HE; Khan, AJ; Kumar, K; Patel, U; Quaye, G; Varghese, M | 1 |
Daschner, FD; Pelz, K; Petersen, EE; Trennhäuser, M | 1 |
Berthon, G; Brisson, AM; Fourtillan, JB | 1 |
D'Elia, JA; Kaldany, A; Kaye, WA; Miller, DG; Yoburn, DC | 1 |
Becker, TM; Freimer, EH; Raeder, R; Ribner, BS | 1 |
Jenkinson, SG | 1 |
Edson, RS; Hermans, PE; Washington, JA; Yu, PK | 1 |
Kawabata, T; Miyahara, T; Nakamura, M; Shimada, J; Sugeno, K; Ueda, Y; Yamaji, T; Yoshida, T | 1 |
Flournoy, DJ; Perrymann, F; Qadri, SM | 1 |
Brouwers, J; Davies, BI; Debruyne, H; Maesen, FP; Nelissen-Wamper, M; Salemans, T | 1 |
Chattopadhyay, B; Curnow, SR; Hall, I | 1 |
Arai, T; Kato, H; Miyano, T; Nittono, H; Suruga, K | 1 |
Gabor, EP; Lee, S; Spira, S | 1 |
Decazes, JM; Meulemans, A; Regnier, B; Vachon, F; Witchitz, JL; Wolff, M | 1 |
Decazes, JM; Meulemans, A; Modai, J; Vittecoq, D; Wolff, M | 1 |
Abbruzzese, JL; Laskin, OL; Lipsky, JJ; McGaughey, MD; Rocco, LE; Skubitz, KM | 1 |
Bal'a, F; Kantarjian, H; Osseiran, M; Tannir, N; Uwaydah, M | 1 |
Carson, HB; Heller, AS; Koch, TB; Schentag, JJ; Walczak, P | 1 |
Aoyama, S; Cho, N; Doi, S; Fujimoto, A; Fukuda, T; Fukunaga, K; Haraguchi, H; Hayashi, S; Hirabayashi, K; Hiraoka, O; Hogaki, M; Ibaragi, K; Jujii, K; Kamigawara, Y; Kamiyoshi, S; Kashiwakura, T; Kobayashi, H; Kondo, I; Kunii, K; Kurasawa, S; Matsuda, S; Matsumoto, Y; Morimoto, N; Motomura, R; Muronosono, E; Nakai, T; Nakamura, H; Nakanishi, K; Ninomiya, K; Okada, E; Oniki, K; Ozawa, M; Risai, T; Saita, K; Sawaragi, I; Seki, K; Shimizu, H; Shimizu, T; Shirafuji, H; Shirakawa, K; Sugimoto, O; Tabei, T; Takase, Z; Tanno, M; Teramoto, C; Watanabe, K; Yamabe, T; Yamada, F; Yamamoto, K; Yuasa, M | 1 |
Hanai, N; Masuda, G; Mukaiyama, T; Negishi, M; Thoma, T; Uchikawa, S; Yamazaki, E; Young, C | 1 |
Dusehu, E; Lallement, PY; Philippe, JM; Veyssier, P | 1 |
Geheber, CE; Kolb, L; Stone, HH | 1 |
Gonzenbach, HR; Sonnabend, W | 2 |
Fiser, I; Klech, H | 1 |
Clark, JK; Manzella, JP | 1 |
Berk, SL; Verghese, A | 1 |
Jones, SR; Kimbrough, RC | 1 |
McCall, CE; Pegram, PS; Salzer, W | 1 |
Lascola, RJ; Reitberg, DP; Schentag, JJ; Van Tyle, JH; Walczak, P; Wels, PB | 1 |
Ahlert, G; Hautmann, R; Pranada, F | 1 |
Blanco, JD; Castaneda, YS; Duff, P; Gibbs, RS; St Clair, PJ | 1 |
Barry, AL; Gavan, TL; Jones, RN; Preston, DA; Thornsberry, C | 1 |
Luper, WE; Slonaker, CE | 1 |
Arnolds, M; David, MF; Fosse, T; Gallais, H; Garnier, JM; Giraud, F; Raoult, D | 1 |
Parks, DB; Uri, JV | 1 |
Armengaud, M; Aubertin, J; Bertrand, A; Carbon, C; Dureux, JB; Gouin, F; Goulon, M; Leng, B; Motin, J; Mouton, Y; Portier, H; Salord, JC; Veyssier, P | 1 |
Fitzgerald, RH | 1 |
Fitzpatrick, SB; Rosenstein, BJ | 1 |
Boutron, HF; Brocard, JF; Fries, D; Merdjan, H; Pocheville, M; Singlas, E | 1 |
Fernández Epifanio, JL; Gómez-Acebo, F; Palenque, E; Rodríguez Otero, JJ; Scarpellini Vera, A | 1 |
Berk, SL; Thomas, CT; Thomas, E | 1 |
Gadebusch, HH; Shungu, DL; Weinberg, E | 1 |
Pechère, JC | 1 |
Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
Gerding, DN; Hall, WH; Opfer, BJ | 1 |
Durack, DT; Lang, SD | 1 |
Baker, CN; Jones, RN; Thornsberry, C | 1 |
Alexander, GA; Crawford, SA; Jorgensen, JH | 3 |
Durack, DT; Edwards, DJ; Lang, SD | 1 |
Baker, S; Livingston, R; Wise, R | 1 |
McCracken, GH; Nelson, JD; Shelton, S | 1 |
Barry, AL; Jones, RN; Thornsberry, C | 1 |
Hewitt, WL; Hindler, JA; Kurtz, TO; Martin, WJ; Winston, DJ; Young, LS | 1 |
Bryk, DA; Panwalker, AP; Trager, GM; White, GW; Zimelis, VM | 1 |
Loock, CA; McCracken, GH; Schaad, UB; Thomas, ML | 2 |
Gilchrist, MJ; Spelhaug, DR; Washington, JA | 1 |
Verbist, L; Verhaegen, J | 1 |
Ehret, J; Eickhoff, TC | 1 |
Lareng, MB; Lefèvre, JC; Prère, MF | 1 |
Durosoir, JL; Saliou, P; Thabaut, A | 1 |
Eley, A; Greenwood, D; O'Grady, F; Pearson, N | 1 |
Hanslo, D; King, A; Phillips, I; Shannon, K; Warren, C | 1 |
Bermudez, RH; Nevarez, M; Ramirez-Ronda, CH; Saavedra, S | 1 |
Durack, DT; Perfect, JR | 2 |
Verbist, L | 1 |
Armengaud, M; Barza, M; Cherubin, CE; Corrado, ML; Landesman, SH; Shah, PM | 1 |
Slack, MP | 1 |
Fox, JM; Quall, CO; Woolfrey, BF | 1 |
Cherubin, CE; Corrado, ML; Landesman, SH; Sierra, MF | 1 |
Livermore, DM; Williams, JD; Williams, RJ | 1 |
Fu, KP; Neu, HC | 1 |
Forsgren, A | 1 |
Baumgärtner, M; Dickgiesser, N; Müller, S; Wundt, W | 1 |
Gootz, TD; Martin, RR; Moellering, RC; Perkins, RL; Sanders, CC; Sanders, WE; Strike, DG | 1 |
Blaser, J; Bonetti, A; Lüthy, R; Siegenthaler, W; Simmen, H; Wise, R | 1 |
LeFrock, JL; Miller, MA; Vercler, MJ | 1 |
Brogard, JM; Comte, F | 1 |
Weinstein, AJ | 1 |
Braveny, I; Elsser, R; Machka, K | 1 |
Grimm, L; McCracken, GH; Nelson, JD | 1 |
Labthavikul, P; Neu, HC | 1 |
Neu, HC | 1 |
Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
Klastersky, J; Lagast, H; Zinner, SH | 1 |
Cherubin, CE; Corrado, ML; Gombert, ME; Shulman, M; Sierra, MF | 1 |
Fass, RJ | 1 |
Farrar, WE; Rotstein, C | 1 |
Beskid, G; Cleeland, R; Grimm, LM; McCracken, GH; Nelson, JD; Schaad, UB | 1 |
Ahonkhai, VI; Cherubin, CE; Shulman, MA; Sierra, MF | 1 |
Kawakita, J; Kawamura, N; Ohkoshi, M; Okada, K; Satake, Y | 1 |
Peters, G; Pulverer, G | 1 |
Aronoff, GR; Blase, DK; Connors, BA; Evan, AP; Gattone, VH; Luft, FC | 1 |
Craig, WA; Greenfield, RA; Kurzynski, TA | 1 |
Acar, JF; Goldstein, F; Gutmann, L; Kitzis, MD; Nasnas, R | 1 |
Chanal, M; Cluzel, R; Glanddier, Y; Sirot, D; Sirot, J | 1 |
Traub, WH | 1 |
Baumgärtner, M; Grehn, M; Wundt, W | 1 |
Drew, WL; Mintz, L | 1 |
Ernest, KD; Magnussen, CR; Sammartino, MT | 1 |
Ehrenkranz, NJ; Hoffman, TA | 1 |
Horiuchi, N; Kanai, M; Kawakami, Y; Okimura, Y | 1 |
Pranada, F; Pusztai-Markos, Z | 1 |
Bergeron, MG; Simard, P | 1 |
Dunlop, WE; Fabian, TC; Stone, HH; Strom, PR | 1 |
Nightingale, CH; Quintiliani, R | 1 |
Connor, E; Melick, C; Yogev, R | 1 |
Denolf, BL; Lambert, AM; Pyckavet, M; Van Landuyt, HW | 1 |
Belmega, G; Borner, K; Jendroschek, T; Kemmerich, B; Koeppe, P; Lode, H | 1 |
Araki, H; Aramaki, S; Chikaoka, H; Eto, Y; Fujimoto, T; Hachimori, K; Hirama, Y; Ishimoto, K; Kawano, Y; Koga, Y; Matsuo, H; Matsuyuki, M; Minamitani, M; Motohiro, T; Nagayama, K; Nakazawa, S; Narita, A; Nishiyama, T; Sato, H; Shimada, Y; Takajo, N; Tanaka, Y; Tominaga, K; Yamashita, F; Yuasa, T | 1 |
Fujimoto, S; Furuta, I; Harikane, O; Hiromatsu, K; Iimori, M; Kamiki, T; Kodama, J; Kotera, K; Maejima, K; Masutani, T; Matsunaga, K; Miwatani, T; Nishimura, T; Nukina, M; Shimizu, Y; Tabuki, K; Takahashi, M; Takashima, E; Takashima, T; Takeda, Y; Tanaka, M; Yabuuchi, E; Yamanaka, K; Yoshizaki, E | 1 |
Marks, MI | 1 |
Cluzel, R; Garnier, R; Joly, B; Sirot, D; Sirot, J | 1 |
Alpegiani, M; Arcamone, F; Battistini, C; Bedeschi, A; Della Bruna, C; Foglio, M; Franceschi, G; Perrone, E; Sanfilippo, A; Zarini, F | 1 |
Chabbert, YA | 1 |
Fourtillan, JB | 1 |
Bergogne-Berezin, E; Chabbert, YA; Cluzel, R; Courtieu, AL; Dabernat, H; Deforges, L; Duval, J; Witchitz, JL | 1 |
Duez, JM; Kazmierczak, A; Kohli, E; Pechinot, A; Tremeaux, JC | 1 |
Labia, R | 1 |
Fillastre, JP; Humbert, G; Leroy, A | 2 |
Brisson, AM; Fourtillan, JB | 1 |
Bégué, P; Brun, Y; Fleurette, J; Floret, D; Monnet, P; Safran, C | 1 |
Coomans, D; Imbert, Y; Leng, B | 1 |
Carbon, C | 1 |
Dupeyron, JP; Peter, JD; Rigolot, JC | 1 |
Acar, JF | 1 |
Garzone, P; Lyon, J; Yu, VL | 1 |
Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G | 1 |
Acar, JF; Bure, A; Christol, D; Courtieu, AL; Dabernat, H; Deforges, L; Duval, J; Kitzis, D; Le Van Thoi, J; Soussy, CJ | 1 |
Hara, K; Kanda, T; Saito, A; Sawatari, K; Toro, J | 1 |
Knothe, H | 1 |
Meyer, RD; Pasiecznik, K | 1 |
Schaad, UB | 1 |
Cohen, SH; Demling, R; Franti, CE; Gunther, R; Hoeprich, PD; Merry, JM; Miner, DJ | 1 |
Asahi, Y; Isono, M; Kesado, T; Ueno, K; Watanabe, K | 1 |
Azuma, K; Nishino, T; Saito, M; Tanino, T | 1 |
Antsaklis, A; Aravantinos, D; Daikos, GK; Gazis, J; Giamarellou, H; Petrikkos, G | 1 |
Furukawa, S; Matsuo, K; Tsuzaki, Y; Uete, T | 1 |
Inamatsu, T; Matsuda, T; Shimada, K; Urayama, K | 1 |
Ericsson, CD; Rowlands, BJ | 1 |
Abe, K; Igari, J; Kosakai, N; Kumamoto, Y; Nagai, T; Nishio, A; Sakai, S; Shigeta, S; Shiraiwa, Y; Tazaki, H | 2 |
Iseki, M; Iwasaki, Y; Iwata, S; Jozaki, K; Kasai, Y; Ogata, T; Osano, M; Sato, Y; Sunakawa, K; Yamashita, R | 1 |
Malottke, R | 1 |
Cherubin, CC; Cleri, D; Corrado, ML; Gombert, M; Landesman, SH | 1 |
Levison, ME; Parsons, JN; Romano, JM | 1 |
Cordera, CS; Pekarek, RS | 1 |
Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Sommers, HM | 2 |
Baker, S; Livingston, R; Wise, R; Wright, N | 1 |
Blanco, JD; Castaneda, YS; Gibbs, RS; St Clair, PJ | 1 |
Alvarez, S; DeMaria, A; Klein, JO; McCabe, WR | 1 |
Hajsig, D; Kapun, D; Muic, V; Skalova, R | 1 |
Krasemann, C; Werner, H | 1 |
Eykyn, SJ; King, BA; Phillips, I; Shannon, KP; Warren, CA | 1 |
Kameda, Y; Kuwahara, S; Matsuura, S; Mayama, M; Yoshida, T | 1 |
Komatsu, Y; Nishikawa, T | 1 |
Bulger, RR; Washington, JA | 1 |
Mirrett, S; Reimer, LG; Reller, LB | 1 |
Anderson, DC; Feigin, RD; Hinds, DB; Kaplan, SL; Mason, EO | 1 |
Richmond, MH | 1 |
Clarke, AM; Zemcov, SJ | 1 |
Barry, AL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
McCracken, GH; Schaad, UB; Thomas, ML; Threlkeld, N | 1 |
Anderson, DC; Feigin, RD; Garcia, H; Kaplan, SL; Kvernland, SJ; Loiselle, EM; Mason, EO; Mintz, AA | 1 |
Motokawa, K; Murakami, K; Takasuka, M; Yoshida, T | 1 |
Cunningham, FG; DePalma, RT; Hemsell, DL; Kappus, S; Nobles, B; Roark, M | 1 |
Yu, VL | 1 |
Bolton, WK; Overby, TL; Sande, MA; Scheld, WM; Spyker, DA | 1 |
Diven, W; Garzone, P; Lyon, J; Pasculle, W; Yu, VL; Zuravleff, J | 1 |
Polk, RE; Stephens, GH | 1 |
Murakami, K; Yoshida, T | 2 |
Bergeron, MG; Claveau, S; Simard, P | 1 |
Hall, WH; Opfer, BJ | 1 |
Czerwinski, AW; Lam, M; Manion, CV | 1 |
Aronoff, GR; Kleit, SA; Luft, FC; Mong, SA; Sloan, RS | 1 |
Bolton, WK; Donowitz, GR; Sande, MA; Scheld, WM; Spyker, DA | 1 |
Bodey, GP; Estey, EH; Ho, DH; Weaver, SS | 1 |
Malow, JB; Panwalker, AP; Porembski, PE; Ramirez, CA; Trager, GM; Zar, FA | 1 |
Tofte, RW | 1 |
Kohler, F; Schassan, HH; Seidel, H; Wittmann, DH | 1 |
Bongaerts, GP; Bruggeman-Ogle, KM; Mouton, RP; van Gestel, M | 1 |
Goldstein, E; Hoeprich, PD; Nolan, SM; Olson, DA | 1 |
Aziz, MT; Kumar, A | 1 |
Gorrochategui, M; Holt, RJ; Perez, C | 1 |
Nelson, RE; Washington, JA | 1 |
Bedford, KA; Wills, PJ; Wise, R | 1 |
Avent, CK; Cobbs, CG; Dismukes, WE; Elliott, AM; Livingston, WK | 1 |
Einhorn, N; Hutson, D; Levi, JU; Livingstone, A; Malinin, TI; Martinez, OV; Zeppa, R | 1 |
Coleman, DL; Hardin, TC; Miner, DJ; Shepherd, AM | 1 |
Jacobson, EJ; Nissenson, AR; Zahrowski, JJ | 1 |
Chu, ML; Harms, JL; Liu, C | 1 |
Chou, K; Kusunoki, Y; Maruyama, S; Sanae, N; Takimoto, M; Yoshioka, H | 1 |
Nagamatsu, I; Ota, H; Takahashi, S; Takase, A; Togashi, K | 1 |
Aoyama, R; Fujita, M; Haneda, S; Izumi, Y; Nagata, K | 1 |
Chikaoka, H; Hirama, Y; Iwasaki, A; Nakazawa, S; Narita, A; Niino, K; Oka, S; Sato, H; Suzuki, H | 1 |
Akita, H; Hara, N; Hirose, M; Hotta, M; Ichihashi, Y; Morikawa, Y; Nanri, S; Sunakawa, K; Tojo, M; Yamashita, N | 1 |
Fujiwara, T; Haruta, T; Kobayashi, Y; Kuroki, S; Morikawa, Y; Okura, K | 1 |
Arimasu, O; Fujii, R; Hiraiwa, M; Mashiko, J; Matsueda, Y; Meguro, H; Ozawa, S; Tohgo, T | 1 |
Hachimori, K; Minamitani, M; Tomori, N | 1 |
Hogaki, M; Matsumoto, Y; Muronosono, E | 1 |
Abe, H; Bekki, E; Hashimoto, I; Hirasawa, S; Katoh, H; Matsuda, S; Mikami, J; Nakamura, T; Sawada, Y | 2 |
Iwata, Y; Kurosaki, T; Nakamura, A; Okimoto, U; Saito, N; Sato, T; Sugaya, N; Terashima, I; Uehara, S | 1 |
Hoshina, H; Ichihashi, H; Ide, K; Yanagisawa, K | 1 |
Hori, M; Kumagai, K; Kurosu, Y; Sugita, M; Takahashi, T; Toyonaga, Y | 1 |
Inokuma, K; Iwai, N; Osuga, T; Sasaki, A; Taneda, Y | 1 |
Hiromatsu, K; Nishimura, T; Tabuki, K; Takagi, M; Takashima, T | 1 |
Shimada, K | 1 |
Crossley, KB; Rotschafer, J; Solliday, J; Tofte, RW | 1 |
Lentino, JR; Moore, E; Rytel, MW | 1 |
Butler, TF; Mahoney, DF; Turner, JR | 1 |
Vuye, A | 1 |
Kimura, Y; Konaka, R; Kuruma, K; Nishimura, R; Yoshida, T | 1 |
Afarian, J; Ehrlich, SL; Kass, EH; O'Brien, TF; Pennington, JE; Platt, R | 1 |
Bean, B; Fasching, CE; Gerding, DN; Korchik, WP; Peterson, LR | 1 |
Neu, HC; Srinivasan, S | 1 |
Busuttil, RW; Kurtz, TO; Winston, DJ; Young, LS | 1 |
Kosaki, G; Ogawa, M; Suginaka, H; Takata, N | 1 |
Dillon, HC | 1 |
Aravind, MK; Buckley, JA; Dajani, AS; Kauffman, RE; Thirumoorthi, MC | 1 |
Levy, RL; Saunders, RL | 1 |
Wills, PJ; Wise, R; Wright, N | 1 |
Pedler, SJ | 1 |
Diven, WF; Lyon, J; Obermeyer, BD; Wolen, RL; Yu, VL; Zuravleff, J | 1 |
Kline, BJ; Markowitz, SM; Polk, RE | 1 |
Barza, M; Baum, J; Kane, A | 1 |
Komatsu, Y; Murakami, K; Nishikawa, T | 1 |
Levison, ME; Poporad, G; Romano, J; Snepar, R | 1 |
Barson, WJ; Durrell, DE; Nahata, MC | 1 |
Hajsig, D; Skalova, R; Smerdel, S | 1 |
Adamsson, L; Dornbusch, K; Gezelius, L; Hallander, H | 1 |
Aronoff, GR; Luft, FC; Sloan, RS | 1 |
Harada, Y; Okamoto, T; Teshima, K | 1 |
Fahd, S; Faris, BM; Jaafar, M; Jabbour, N; Uwaydah, MM | 1 |
Feigin, RD; Kaplan, SL; Mason, EO | 1 |
Harada, Y; Muraoka, Y; Nara, H; Yoshizaki, T | 1 |
Clark, J; D'Elia, JA; Hochman, R; Kaldany, A; Miller, DG; Rolla, AR; Thomas, S | 1 |
Harauchi, T; Hirata, M; Itoh, F; Mizushima, Y; Sato, K | 1 |
Ahn, B; Chay, K; Jung, Y; Lee, M; Song, D; Yang, S | 1 |
Kariyazono, H; Moriyama, Y; Nakamura, K; Shinkawa, T; Taira, A; Toyohira, H; Yamada, K | 1 |
Dideberg, O; Garau, G; Hernandez, JF; Kahn, R; Nauton, L | 1 |
Bongaerts, GP; Mouton, RP; van Gestel, MH | 1 |
14 review(s) available for moxalactam and cephalosporin c
Article | Year |
---|---|
Determinants of antibiotic-associated hypoprothrombinemia.
Topics: Animals; Anti-Bacterial Agents; Blood Coagulation; Cephalosporins; Humans; Hypoprothrombinemias; In Vitro Techniques; Moxalactam; Risk; Tetrazoles | 1987 |
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Moxalactam; Penicillins; Postoperative Complications; Pregnancy; Socioeconomic Factors | 1986 |
The cephalosporin antibiotic agents--III. Third-generation cephalosporins.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Humans; Moxalactam | 1985 |
Cephalosporin induced coagulopathies.
Topics: Adult; Aged; Bleeding Time; Blood Platelet Disorders; Cephalosporins; Child; Humans; Hypoprothrombinemias; Infant; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Vitamin K 1; Vitamin K Deficiency | 1984 |
New drug evaluations: moxalactam (Moxam, Eli Lilly).
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Drug Administration Schedule; Humans; Kinetics; Moxalactam | 1982 |
[Review [new antibiotics series IV]: latamoxef (author's transl)].
Topics: Adult; Animals; Bacterial Infections; Cephalosporins; Cephamycins; Child, Preschool; Dogs; Female; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Mice; Moxalactam; Rabbits; Rats | 1982 |
Discovery and development of Moxalactam (6059-S): the chemistry and biology of 1-oxacephems.
Topics: Animals; Antibodies, Bacterial; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Dogs; Drug Resistance, Microbial; Female; Guinea Pigs; Haplorhini; Humans; Kidney; Kinetics; Male; Mice; Moxalactam; Peritonitis; Rabbits; Rats; Reproduction | 1981 |
[Pharmacokinetics, in vitro activity and clinical experience with lamoxactam].
Topics: Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Drug Stability; Humans; Kinetics; Moxalactam | 1983 |
Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Blood-Brain Barrier; Cefamandole; Cefotaxime; Cefoxitin; Cephaloridine; Cephalosporins; Cephalothin; Cephamycins; Child, Preschool; Enterobacteriaceae; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Middle Aged; Moxalactam; Pseudomonas aeruginosa | 1981 |
Antipseudomonal beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Lactams; Moxalactam; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1981 |
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summaries.
Topics: Bacteria; Bacterial Infections; Bacteroides fragilis; Cefamandole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Humans; Moxalactam; Pseudomonas aeruginosa | 1983 |
The cephalosporin compounds in severe neonatal infection.
Topics: Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Enterobacteriaceae Infections; Humans; Infant, Newborn; Meningitis; Moxalactam; Sepsis | 1984 |
27 trial(s) available for moxalactam and cephalosporin c
Article | Year |
---|---|
[Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study].
Topics: Aged; Aged, 80 and over; Azoles; Blood Coagulation Disorders; Cefoperazone; Cefotaxime; Cephalosporins; Female; Humans; Male; Moxalactam; Pilot Projects; Protein C; Prothrombin Time; Random Allocation; Tetrazoles; Urinary Tract Infections; Vitamin K Deficiency | 1989 |
Serious postoperative bleeding associated with a single intravenous dose of cefuroxime and metronidazole.
Topics: Aged; Cefuroxime; Cephalosporins; Colonic Neoplasms; Drug Combinations; Female; Gastrointestinal Hemorrhage; Humans; Male; Metronidazole; Middle Aged; Moxalactam; Postoperative Complications; Random Allocation; Rectal Neoplasms | 1986 |
Effects of cephalosporins and carumonam on blood coagulation.
Topics: Blood Coagulation; Blood Coagulation Tests; Cefotaxime; Ceftriaxone; Cephalosporins; Clinical Trials as Topic; Humans; Moxalactam; Random Allocation; Structure-Activity Relationship | 1987 |
Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Ceftizoxime; Cephalosporins; Double-Blind Method; Female; Humans; Hypoprothrombinemias; Male; Middle Aged; Moxalactam; Peritonitis; Pneumonia; Prothrombin Time; Random Allocation | 1987 |
Pathophysiology and management of postcesarean endomyometritis.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Cesarean Section; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Moxalactam; Penicillins; Postoperative Complications; Pregnancy; Socioeconomic Factors | 1986 |
Randomized comparison of five irrigation solutions at cesarean section.
Topics: Ampicillin; Cefamandole; Cephalosporins; Cephapirin; Cesarean Section; Double-Blind Method; Endometritis; Female; Humans; Moxalactam; Pregnancy; Premedication; Random Allocation; Solutions; Therapeutic Irrigation; Urinary Tract Infections | 1986 |
Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Cephalosporins; Cephradine; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neutropenia; Random Allocation; Tobramycin | 1985 |
FDA approves new antibiotic for surgical infections, meningitis.
Topics: Cephalosporins; Cephamycins; Child; Clinical Trials as Topic; Humans; Meningitis, Haemophilus; Moxalactam; Surgical Wound Infection; United States; United States Food and Drug Administration | 1982 |
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cephalosporins; Cephamycins; Child; Double-Blind Method; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Kanamycin; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Prospective Studies; Random Allocation; Ticarcillin | 1982 |
On the disulfiram-like activity of moxalactam.
Topics: Acetaldehyde; Adult; Animals; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Chromatography, Gas; Disulfiram; Ethanol; Female; Humans; Kinetics; Male; Moxalactam; Rats | 1982 |
Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers.
Topics: Adult; Cefazolin; Cephalosporins; Cephamycins; Half-Life; Humans; Infusions, Parenteral; Injections, Intramuscular; Kinetics; Male; Moxalactam | 1981 |
Randomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adults.
Topics: Adult; Cefazolin; Cephalosporins; Cephamycins; Clinical Trials as Topic; Humans; Moxalactam; Random Allocation; Urinary Tract Infections | 1982 |
Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Clinical Trials as Topic; Double-Blind Method; Female; Fever; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Streptococcal Infections; Tobramycin; Urinary Tract Infections | 1983 |
Moxalactam versus gentamicin-clindamycin in surgical sepsis. Efficacy and safety.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Postoperative Complications; Prospective Studies; Random Allocation | 1983 |
A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis.
Topics: Abdomen; Adult; Age Factors; Aged; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infections; Male; Middle Aged; Moxalactam; Nutrition Disorders; Prognosis; Random Allocation; Staphylococcal Infections; Staphylococcus; Tobramycin | 1983 |
A double-blind, randomized comparison of moxalactam versus clindamycin-gentamicin in treatment of endomyometritis after cesarean section delivery.
Topics: Adult; Cephalosporins; Cephamycins; Cesarean Section; Clindamycin; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Drug Hypersensitivity; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Infant, Newborn; Moxalactam; Pregnancy; Puerperal Infection; Random Allocation | 1983 |
Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Humans; Kinetics; Male; Moxalactam; Stereoisomerism; Time Factors | 1981 |
Third-generation cephalosporins for polymicrobial surgical sepsis.
Topics: Abscess; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Peritonitis; Postoperative Complications; Random Allocation; Surgical Wound Infection | 1983 |
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
Topics: Adult; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Moxalactam | 1983 |
[Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
Topics: Adult; Bacterial Infections; Cephalosporins; Cephamycins; Clinical Trials as Topic; Escherichia coli Infections; Female; Focal Infection; France; Humans; Male; Moxalactam; Sepsis | 1983 |
[Clinical evaluation of moxalactam].
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Clinical Trials as Topic; Critical Care; Cross Infection; Humans; Meningitis; Moxalactam; Sepsis; Urinary Tract Infections | 1983 |
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections | 1983 |
Comparative studies of antibiotic therapy after penetrating abdominal trauma.
Topics: Abdominal Injuries; Adolescent; Cefoxitin; Cephalosporins; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Moxalactam; Premedication; Prospective Studies; Random Allocation; Time Factors; Tobramycin; Wound Infection; Wounds, Gunshot; Wounds, Stab | 1984 |
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
Topics: Adult; Cefazolin; Cephalosporins; Cephamycins; Humans; Injections, Intramuscular; Injections, Intravenous; Kinetics; Male; Moxalactam | 1981 |
[Moxalactam - a beta-lactam antibiotic in the monotherapy of severe infections in surgery. Clinico-bacteriological study of 35 patients].
Topics: Abdomen; Adolescent; Adult; Aged; Candidiasis; Cephalosporins; Cephamycins; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Surgical Wound Infection | 1981 |
Clinical evaluation of moxalactam.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Moxalactam; Pneumonia; Sepsis | 1981 |
[Clinical application of 6059-S in the field of obstetrics and gynecology. Effects on gynecological infection and infection of trimester of pregnancy (author's transl)].
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Drug Evaluation; Estriol; Female; Fetal Growth Retardation; Genital Diseases, Female; Humans; Middle Aged; Moxalactam; Placental Function Tests; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Progesterone | 1981 |
332 other study(ies) available for moxalactam and cephalosporin c
Article | Year |
---|---|
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cefozopran; Cefpirome; Cephalosporins; Drug Stability; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Tazobactam | 1991 |
[Protein binding of various cephems in healthy subjects and patients with chronic renal failure].
Topics: Adult; Cephalosporins; Cephalothin; Fatty Acids, Nonesterified; Female; Humans; Kidney Failure, Chronic; Lipase; Male; Middle Aged; Moxalactam; Peritoneal Dialysis; Protein Binding; Renal Dialysis; Serum Albumin | 1991 |
The incidence and beta-lactam resistance of Proteus vulgaris in hospital infections: the last decade.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Aztreonam; Bacteremia; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Phenotype; Proteus Infections; Proteus vulgaris; Spain; Urinary Tract Infections | 1991 |
[Acquired coagulopathy caused by administration of parenteral broad-spectrum antibiotics].
Topics: Aged; Aged, 80 and over; Biomarkers; Cephalosporins; Cephamycins; Hemorrhagic Disorders; Humans; Male; Moxalactam; Parenteral Nutrition, Total; Protein Precursors; Prothrombin; Vitamin K Deficiency | 1991 |
[A clinical study of asymptomatic bacteriospermia].
Topics: 4-Quinolones; Anti-Infective Agents; Cephalexin; Cephalosporins; Enterococcus faecalis; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Moxalactam; Quinolones; Semen; Staphylococcus epidermidis; Streptococcus agalactiae | 1990 |
Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats.
Topics: Animals; Animals, Newborn; Bacteria; Cefepime; Cefotaxime; Cephalosporins; Male; Meningitis; Mice; Microbial Sensitivity Tests; Moxalactam; Rats; Rats, Inbred Strains | 1990 |
Studies on oxacephem antibiotics: comparison of the effects of 1-oxa and 1-thia cephalosporins on blood coagulation activities and vitamin K metabolism in rats.
Topics: Animals; Blood Coagulation; Cephalosporins; Factor VII; Fibrinogen; Male; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Inbred Strains; Vitamin K; Vitamin K Deficiency | 1989 |
Cephalosporin-induced hypoprothrombinemia: possible role for thiol methylation of 1-methyltetrazole-5-thiol and 2-methyl-1,3,4-thiadiazole-5-thiol.
Topics: Animals; Azoles; Biotransformation; Carbon-Carbon Ligases; Cephalosporins; Chromatography, High Pressure Liquid; Glutamates; Glutamic Acid; Humans; Hypoprothrombinemias; Kidney; Kinetics; Ligases; Male; Methylation; Methyltransferases; Microsomes, Liver; Moxalactam; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Tetrazoles; Thiadiazoles | 1985 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
Phase I clinical studies of 7432-S: effect of 7432-S on platelet aggregation and blood coagulation.
Topics: Adenosine Diphosphate; Adult; Animals; Anti-Bacterial Agents; Blood Coagulation; Cefaclor; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalexin; Cephalosporins; Collagen; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Male; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Kinetics and action of N-methylthiotetrazole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moiety.
Topics: Azoles; Cefoperazone; Cefotetan; Cephalosporins; Cephamycins; Humans; Hypoprothrombinemias; Moxalactam; Population Surveillance; Risk Factors; Tetrazoles | 1988 |
In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Cefotaxime; Cefoxitin; Cephalosporins; Clindamycin; Clostridium; Moxalactam; Peptococcaceae; Propionibacterium acnes | 1988 |
A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds.
Topics: Aztreonam; beta-Lactamases; Cephalosporins; Hydrolysis; Imipenem; Kinetics; Moxalactam; Substrate Specificity | 1988 |
Bacterial meningitis: is there a "best" antimicrobial therapy?
Topics: Cefoperazone; Ceftazidime; Ceftriaxone; Cefuroxime; Cephalosporins; Child; Humans; Infant, Newborn; Meningitis; Meningitis, Haemophilus; Moxalactam | 1987 |
Treatment of Salmonella meningitis and brain abscess with the new cephalosporins: two case reports and a review of the literature.
Topics: Brain Abscess; Ceftriaxone; Cephalosporins; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Moxalactam; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium | 1987 |
[Laboratory and clinical studies of flomoxef].
Topics: Adult; Bacteria; Bacterial Infections; Cefazolin; Cefmetazole; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Infusions, Intravenous; Klebsiella; Male; Middle Aged; Moxalactam | 1987 |
[Free methyltetrazolethiol concentrations in men subjected to intravenous administration of cephems with methyltetrazolethiol].
Topics: Aldehyde Oxidoreductases; Azoles; Biotransformation; Cefmetazole; Cefoperazone; Cephalosporins; Cephamycins; Disulfiram; Humans; Injections, Intravenous; Liver; Liver Cirrhosis; Middle Aged; Moxalactam; Tetrazoles | 1987 |
Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cefoxitin; Cephalosporins; Drug Resistance, Microbial; Imipenem; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Moxalactam; Nephelometry and Turbidimetry; Thienamycins | 1986 |
Patient stratification in intra-abdominal infection.
Topics: Aged; Bacteria; Bacterial Infections; Cefotetan; Cefuroxime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Peritonitis | 1987 |
Antibiotic prophylaxis in vascular surgery: pharmacokinetic study of four commonly used cephalosporins.
Topics: Animals; Aorta; Bacterial Infections; Cefamandole; Cefazolin; Cefoxitin; Cephalosporins; Dogs; Escherichia coli Infections; Kinetics; Moxalactam; Muscles; Staphylococcal Infections; Time Factors; Tissue Distribution; Vascular Surgical Procedures | 1986 |
[In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
Topics: Bacteria; Cefotaxime; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Microbial Sensitivity Tests; Moxalactam | 1986 |
Synthesis and antimicrobial activity of 7 alpha-methoxypyrimidinyl-ureidocephalosporins.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ceftazidime; Cephalosporins; Mice; Microbial Sensitivity Tests; Moxalactam; Pyrimidines | 1986 |
Comparative pharmacokinetic analysis of latamoxef and CPW 86-363, a novel carboxy-pyrazol-cephalosporin and formation of N-methyl-thiotetrazole.
Topics: Adult; Azoles; Biotransformation; Blood Coagulation Disorders; Cephalosporins; Humans; Kinetics; Male; Moxalactam; Structure-Activity Relationship; Tetrazoles | 1987 |
Alterations of pharmacokinetic properties of gentamicin, penicillin G and two cephalosporins in septicaemic rabbits.
Topics: Animals; Cephalosporins; Gentamicins; Male; Moxalactam; Penicillin G; Rabbits; Sepsis | 1987 |
Chemotherapy of bacterial meningitis in children.
Topics: Ampicillin; Australia; Cephalosporins; Child; Chloramphenicol; Humans; Meningitis, Haemophilus; Moxalactam | 1987 |
[In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
Topics: Cefotaxime; Cefoxitin; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Moxalactam; Species Specificity | 1986 |
Cephamycin inactivation due to enzymatic hydrolysis by beta-lactamase from Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Cephamycins; Clavulanic Acid; Clavulanic Acids; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Penicillin G | 1985 |
In vitro antibacterial activity of SK&F 88070 against aerobic gram-positive and gram-negative cocci and Haemophilus influenzae.
Topics: Ampicillin; Cefmenoxime; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Methicillin; Microbial Sensitivity Tests; Moxalactam | 1985 |
Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Biological Availability; Blood Proteins; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Male; Mice; Microbial Sensitivity Tests; Moxalactam; Protein Binding | 1985 |
Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?
Topics: Bile; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Half-Life; Humans; Kinetics; Moxalactam | 1985 |
Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
Topics: Amikacin; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Synergism; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1985 |
The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Cephalosporins; Enterobacteriaceae; Gentamicins; Imipenem; Microbial Sensitivity Tests; Moxalactam; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Ticarcillin | 1985 |
Third generation cephalosporins--a panacea for intensive care patients?
Topics: Bacterial Infections; Cephalosporins; Cross Infection; Humans; Intensive Care Units; Moxalactam | 1985 |
New cephalosporins: in-vitro activity against gram-negative bacilli and suggestions for possible clinical use.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Humans; Moxalactam; Tobramycin | 1984 |
Lack of interference with creatinine assays by four cephalosporin-like antibiotics.
Topics: Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Creatinine; False Positive Reactions; Humans; Moxalactam | 1984 |
Diffusibility of the newer cephalosporins into human interstitial fluids.
Topics: Adolescent; Adult; Blood Proteins; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Diffusion; Extracellular Space; Humans; Male; Middle Aged; Moxalactam; Protein Binding | 1984 |
Affinity of cefmenoxime for beta-lactamases: an analysis.
Topics: Bacteria; beta-Lactamases; Cefmenoxime; Cefotaxime; Cephalosporinase; Cephalosporins; Hydrolysis; Kinetics; Moxalactam; Penicillinase | 1984 |
Interaction between moxalactam and alcohol.
Topics: Adolescent; Adult; Blood Pressure; Cephalosporins; Cephamycins; Cystic Fibrosis; Drug Interactions; Ethanol; Female; Humans; Male; Moxalactam; Vomiting | 1980 |
Enzyme-mediated resistance of Bacteroides fragilis to moxalactam.
Topics: Bacteroides fragilis; beta-Lactamases; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam | 1981 |
Moxalactam.
Topics: Adult; Bacteria; Cephalosporins; Cephamycins; Drug Evaluation; Humans; Infant, Newborn; Meningitis, Haemophilus; Moxalactam | 1981 |
Latamoxef, alias moxalactam.
Topics: Cephalosporins; Cephamycins; Humans; International Cooperation; Moxalactam; Pharmacopoeias as Topic; Terminology as Topic | 1983 |
Severe depletion of vitamin-K-dependent clotting factors during postoperative latamoxef therapy.
Topics: Blood Coagulation; Blood Coagulation Factors; Cephalosporins; Cephamycins; Colectomy; Female; Humans; Middle Aged; Moxalactam; Postoperative Care; Vitamin K; Vitamin K Deficiency | 1983 |
N-methyl-thio-tetrazole inhibition of the gamma carboxylation of glutamic acid: possible mechanism for antibiotic-associated hypoprothrombinaemia.
Topics: Animals; Anti-Bacterial Agents; Azoles; Bacteria; Biotransformation; Cefamandole; Cefoperazone; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Glutamates; Glutamic Acid; Humans; Hypoprothrombinemias; Intestines; Moxalactam; Prothrombin; Rats; Structure-Activity Relationship; Tetrazoles | 1983 |
Latamoxef-associated hypoprothrombinaemia.
Topics: Animals; Cephalosporins; Cephamycins; Dogs; Humans; Hypoprothrombinemias; Moxalactam; Rats | 1983 |
Latamoxef-associated hypoprothrombinaemia.
Topics: Animals; Cephalosporins; Cephamycins; Humans; Hypoprothrombinemias; Kinetics; Moxalactam | 1983 |
Modulating effect of subinhibitory concentrations of compound LY 127935 on the virulence of Escherichia coli in the mouse.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred Strains; Moxalactam; Virulence | 1982 |
Moxalactam in pediatrics.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Kinetics; Meningitis; Moxalactam | 1982 |
Determination of moxalactam by high-performance liquid chromatography.
Topics: Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Humans; Microchemistry; Moxalactam | 1982 |
Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Citrobacter; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Infant, Newborn; Klebsiella Infections; Male; Meningitis; Moxalactam | 1982 |
The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Cephamycins; Enterobacteriaceae; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1982 |
Effect of probenecid on the pharmacokinetics of moxalactam.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Drug Interactions; Humans; Kidney; Kinetics; Male; Middle Aged; Moxalactam; Probenecid | 1982 |
Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Female; Humans; Male; Meningitis; Middle Aged; Moxalactam | 1982 |
Clinical experience with Moxalactam in the treatment of pseudomonal and nonpseudomonal infections.
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Male; Middle Aged; Moxalactam; Pseudomonas Infections | 1982 |
Moxalactam in the therapy of serious infections.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Humans; Microbial Sensitivity Tests; Moxalactam | 1982 |
Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.
Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam | 1982 |
Gram-negative bacillary meningitis. New therapy and changing concepts.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Chloramphenicol; Enterobacteriaceae Infections; Humans; Meningitis; Moxalactam; Pseudomonas Infections | 1982 |
Penetration of moxalactam into CSF.
Topics: Adult; Cephalosporins; Cephamycins; Gram-Negative Anaerobic Bacteria; Humans; Infant, Newborn; Meningitis; Moxalactam | 1982 |
HPLC determination of D and L moxalactam in human serum and urine.
Topics: Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Drug Stability; Humans; Kinetics; Moxalactam; Stereoisomerism; Time Factors | 1982 |
Moxalactam therapy. Its use in chronic suppurative otitis media and malignant external otitis.
Topics: Aged; Cephalosporins; Cephamycins; Chronic Disease; Diabetes Complications; Female; Humans; Male; Mastoiditis; Middle Aged; Moxalactam; Otitis Externa; Otitis Media; Otitis Media, Suppurative; Pseudomonas Infections | 1982 |
In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Cephamycins; Enterobacteriaceae; Imipenem; Microbial Sensitivity Tests; Moxalactam; Staphylococcus; Tobramycin | 1982 |
Pharmacokinetic and clinical evaluation of moxalactam in infants and children.
Topics: Adolescent; Anti-Bacterial Agents; Arthritis, Infectious; Cellulitis; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Female; Half-Life; Humans; Infant; Kinetics; Lymphadenitis; Male; Moxalactam; Osteomyelitis; Pneumonia, Pneumococcal | 1981 |
Synthesis and antibacterial activity of 1-oxacephem derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Cephamycins; Moxalactam; Structure-Activity Relationship | 1982 |
[Moxalactam: use in digestive surgery].
Topics: Cephalosporins; Cephamycins; Gastrointestinal Diseases; Humans; Moxalactam; Surgical Wound Infection | 1982 |
In vitro activity of moxalactam alone and in combination with penicillin against common meningeal pathogens.
Topics: Bacteria; Cephalosporins; Cephamycins; Drug Interactions; Haemophilus influenzae; Meningitis; Microbial Sensitivity Tests; Moxalactam; Neisseria meningitidis; Penicillin G; Penicillin Resistance; Streptococcus pneumoniae | 1982 |
Comparative effects of moxalactam and gentamicin on human polymorphonuclear leukocyte functions.
Topics: Cell Migration Inhibition; Cephalosporins; Cephamycins; Chemotaxis, Leukocyte; Gentamicins; Humans; In Vitro Techniques; Moxalactam; Neutrophils; Phagocytosis | 1982 |
Clinical evaluation of moxalactam.
Topics: Adult; Aged; Anaerobiosis; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam | 1982 |
Moxalactam concentration in human aqueous humor after intravenous administration.
Topics: Adult; Aqueous Humor; Cataract Extraction; Cephalosporins; Cephamycins; Endophthalmitis; Enterobacteriaceae Infections; Female; Humans; Injections, Intravenous; Male; Middle Aged; Moxalactam; Postoperative Complications | 1982 |
In vitro combination effects of cefsulodin, moxalactam and cefoperazone with four aminoglycosides on nonfermenting nosocomial gram-negative bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cefsulodin; Cephalosporins; Cephamycins; Drug Interactions; Humans; Moxalactam | 1982 |
Comparative inhibitory and bactericidal activities of moxalactam and seven other antibiotics against 520 clinical isolates including 65 multi-drug resistant strains.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Culture Media; Humans; Lactams; Microbial Sensitivity Tests; Moxalactam | 1982 |
Coagulopathy associated with the use of moxalactam.
Topics: Abdomen; Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Hypoprothrombinemias; Male; Moxalactam; Vitamin K | 1982 |
Successful treatment of gram-negative bacillary meningitis with moxalactam.
Topics: Amikacin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Male; Meningitis; Middle Aged; Moxalactam | 1982 |
Moxalactam in the treatment of pediatric infections.
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Moxalactam | 1982 |
Clinical and pharmacokinetic evaluation of parenteral moxalactam in infants and children.
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Injections, Intravenous; Kinetics; Male; Moxalactam | 1982 |
In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin.
Topics: Cefoperazone; Cephalosporins; Cephamycins; Moxalactam; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1982 |
Third-generation cephalosporins in the treatment of pneumonia due to Pseudomonas aeruginosa in guinea pigs.
Topics: Animals; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Guinea Pigs; Moxalactam; Pneumonia; Pseudomonas Infections; Ticarcillin; Tobramycin | 1982 |
[Use of moxalactam in intensive care units: clinical and bacteriological results related to serum and bronchial concentrations ].
Topics: Adult; Aged; Cephalosporins; Cephamycins; Critical Care; Cross Infection; Female; Humans; Male; Middle Aged; Moxalactam; Respiratory Tract Infections; Sepsis; Sputum | 1982 |
Theophylline elixir, moxalactam, and a disulfiram reaction.
Topics: Aged; Beer; Cephalosporins; Cephamycins; Disulfiram; Drug Interactions; Ethanol; Humans; Male; Moxalactam; Theophylline | 1982 |
Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli.
Topics: Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Female; Humans; Meningitis; Middle Aged; Moxalactam; Serratia marcescens | 1981 |
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamases; beta-Lactams; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Moxalactam; Thienamycins | 1981 |
Moxalactam pharmacokinetics in children.
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Moxalactam; Time Factors | 1982 |
Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects.
Topics: Adult; Cephalosporins; Cephamycins; Feces; Humans; Injections, Intramuscular; Injections, Intravenous; Kinetics; Male; Middle Aged; Moxalactam; Time Factors | 1982 |
Brucella canis infection in a 17-month-old child successfully treated with moxalactam.
Topics: Arthritis; Brucella; Brucellosis; Cephalosporins; Cephamycins; Humans; Infant; Male; Moxalactam | 1982 |
Moxalactam (Moxam) in the treatment of experimental staphylococcal endophthalmitis.
Topics: Animals; Aqueous Humor; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Endophthalmitis; Injections, Intramuscular; Injections, Intravenous; Moxalactam; Rabbits; Retina; Staphylococcal Infections; Vitreous Body | 1982 |
[Moxalactam (lamoxactam)].
Topics: Adult; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Child; Humans; Infant, Newborn; Moxalactam | 1982 |
Moxalactam disodium compatibility with intramuscular and intravenous diluents.
Topics: Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Color; Drug Incompatibility; Excipients; Hydrogen-Ion Concentration; Injections, Intramuscular; Injections, Intravenous; Moxalactam; Polarography | 1982 |
Maternal and fetal pharmacokinetics of moxalactam given intrapartum.
Topics: Bacteriological Techniques; Cephalosporins; Cephamycins; Cesarean Section; Chromatography, High Pressure Liquid; Female; Fetal Blood; Humans; Infection Control; Kinetics; Moxalactam; Pregnancy; Risk; Uterus | 1982 |
Claims for moxalactam.
Topics: Advertising; Cephalosporins; Cephamycins; Clindamycin; Gentamicins; Humans; Moxalactam | 1982 |
Renal excretion of R- and S-epimers of moxalactam in dogs.
Topics: Animals; Cephalosporins; Cephamycins; Dogs; Glomerular Filtration Rate; Male; Moxalactam; Protein Binding; Stereoisomerism | 1982 |
Clinical evaluation of moxalactam therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Sepsis | 1982 |
Prolonged bleeding times and bleeding diathesis associated with moxalactam administration.
Topics: Adenosine Diphosphate; Aged; Bacterial Infections; Bleeding Time; Blood Platelets; Cephalosporins; Cephamycins; Female; Hemorrhagic Disorders; Humans; Male; Middle Aged; Moxalactam; Platelet Aggregation; Platelet Function Tests | 1983 |
Moxalactam treatment of anaerobic infections in cancer patients.
Topics: Adult; Aged; Anaerobiosis; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Moxalactam; Neoplasms | 1982 |
Bleeding problems.
Topics: Cephalosporins; Cephamycins; Hemorrhage; Humans; Moxalactam; Surgical Wound Infection | 1983 |
Hemorrhage, diarrhea, and superinfection associated with the use of moxalactam.
Topics: Aged; Bacterial Infections; Cephalosporins; Cephamycins; Diarrhea; Hemorrhage; Humans; Hypoprothrombinemias; Middle Aged; Moxalactam | 1983 |
[The cerebrospinal fluid concentration of lamoxactam with reference to the therapy of gram-negative CNS infections].
Topics: Adult; Aged; Bacterial Infections; Brain Injuries; Cephalosporins; Cephamycins; Humans; Meningitis; Middle Aged; Moxalactam; Postoperative Complications | 1982 |
Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Child, Preschool; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Moxalactam | 1983 |
Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections | 1982 |
Clinical and pharmacokinetic evaluation of moxalactam in infants and children.
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Kidney Function Tests; Kinetics; Liver Function Tests; Male; Moxalactam; Pneumonia; Urinary Tract Infections | 1982 |
[Experience with lamoxactam in gynecology: application as a monotherapeutic agent in severe genital infections and determination of its concentration in uterine and tubal tissues].
Topics: Adult; Bacterial Infections; Cephalosporins; Cephamycins; Endometritis; Fallopian Tubes; Female; Genital Diseases, Female; Humans; Middle Aged; Moxalactam; Pelvic Inflammatory Disease; Surgical Wound Infection; Uterus | 1982 |
Sensitive high-performance liquid chromatographic analysis of moxalactam in biological fluids.
Topics: Anti-Bacterial Agents; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Humans; Kinetics; Moxalactam; Time Factors | 1982 |
Moxalactam, bleeding, and renal insufficiency.
Topics: Bacteria; Cephalosporins; Cephamycins; Humans; Hypoprothrombinemias; Intestines; Kidney Diseases; Moxalactam; Nephrectomy; Vitamin K | 1983 |
Treatment of serious infections with moxalactam.
Topics: Abscess; Adult; Ascitic Fluid; Bacterial Infections; Bile; Cephalosporins; Cephamycins; Cerebrospinal Fluid; Escherichia coli; Humans; Moxalactam; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1983 |
Adverse effects of new cephalosporins.
Topics: Animals; Cephalosporins; Cephamycins; Hemorrhage; Humans; Moxalactam; Prothrombin Time; Rats | 1983 |
Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cephalosporins; Cephamycins; Drug Synergism; Gentamicins; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1983 |
Renal disposition of moxalactam in experimental animals as revealed by stop-flow analysis.
Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Cephalosporins; Cephamycins; Dogs; Kidney; Macaca fascicularis; Male; Metabolic Clearance Rate; Moxalactam; p-Aminohippuric Acid; Probenecid; Protein Binding; Rabbits; Species Specificity | 1983 |
In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Humans; Microbial Sensitivity Tests; Moxalactam | 1983 |
Latamoxef (moxalactam) in acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Bronchitis; Cephalosporins; Cephamycins; Chronic Disease; Humans; Kinetics; Microbial Sensitivity Tests; Moxalactam; Sputum; Time Factors | 1983 |
Comparison of in-vitro activity of latamoxef (moxalactam) and ceftazidime against Pseudomonas and Enterobacteriaceae resistant to first generation cephalosporins.
Topics: Ceftazidime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas | 1983 |
Antibiotic excretion into the bile after hepatic-portojejunostomy in biliary atresia.
Topics: Bile; Bile Ducts; Cefmetazole; Cephalosporins; Cephamycins; Child; Child, Preschool; Humans; Infant; Jejunum; Liver; Moxalactam | 1983 |
Coagulopathy associated with moxalactam.
Topics: Adult; Aged; Blood Coagulation Disorders; Cephalosporins; Cephamycins; Female; Humans; Male; Moxalactam | 1983 |
[Treatment of enterobacterial meningitis in adults with intravenous lamoxactam].
Topics: Adult; Aged; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Female; Humans; Injections, Intravenous; Male; Meningitis; Middle Aged; Moxalactam | 1983 |
[Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Kinetics; Male; Meningitis; Middle Aged; Moxalactam | 1983 |
Moxalactam therapy of bacterial meningitis in adults.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Male; Meningitis; Microbial Sensitivity Tests; Middle Aged; Moxalactam | 1983 |
Antibiotic penetration in abdominal infection: a case of tobramycin failure responsive to moxalactam.
Topics: Abdomen; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae Infections; Humans; Male; Middle Aged; Moxalactam; Postoperative Complications; Tobramycin | 1983 |
[Laboratory and clinical studies on latamoxef in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Drug Evaluation; Exudates and Transudates; Female; Genital Diseases, Female; Genitalia, Female; Humans; Middle Aged; Moxalactam; Pregnancy | 1983 |
[Timed bacteriostatic and bactericidal activities of latamoxef against clinical strains of gram-negative bacteria].
Topics: Bacteroides fragilis; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Escherichia coli; Klebsiella; Moxalactam; Serratia marcescens; Time Factors | 1983 |
[Levels of moxalactam in the cerebral ventricles during the treatment of Klebsiella septicemia].
Topics: Cephalosporins; Cephamycins; Cerebral Ventricles; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Moxalactam; Sepsis | 1983 |
[Clinical experience with moxalactam in the treatment of mixed aerobic-anaerobic surgical infections].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Male; Middle Aged; Moxalactam; Postoperative Complications | 1983 |
Effects of moxalactam and cefuroxime on mitogen-stimulated human mononuclear leukocytes.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Cephamycins; Concanavalin A; Humans; Lymphocyte Activation; Mitogens; Monocytes; Moxalactam; Phytohemagglutinins | 1983 |
Moxalactam/amikacin versus ticarcillin/amikacin in granulocytopenic patients.
Topics: Agranulocytosis; Amikacin; Cephalosporins; Cephamycins; Drug Therapy, Combination; Humans; Infections; Kanamycin; Moxalactam; Penicillins; Ticarcillin | 1983 |
Moxalactam and hemorrhage.
Topics: Aged; Cephalosporins; Cephamycins; Diverticulitis; Female; Hemorrhage; Humans; Moxalactam | 1983 |
Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
Topics: Adolescent; Adult; Aged; Anaerobiosis; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Male; Meningitis; Middle Aged; Moxalactam; Peritonitis; Pneumonia; Sepsis; Urinary Tract Infections | 1983 |
Clinical experience in the treatment of complicated urinary tract infection with different doses of moxalactam (lamoxactam).
Topics: Adult; Aged; Bacteria; Cephalosporins; Cephamycins; Female; Humans; Male; Middle Aged; Moxalactam; Urinary Tract Infections | 1983 |
Quality control of moxalactam susceptibility disks.
Topics: Bacteria; Cephalosporins; Cephamycins; Escherichia coli; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Quality Control; Reference Standards; Staphylococcus aureus | 1983 |
Moxalactam-associated platelet dysfunction.
Topics: Aged; Bacterial Infections; Cephalosporins; Cephamycins; Gastrointestinal Hemorrhage; Humans; Male; Moxalactam; Platelet Aggregation | 1983 |
[Value of moxalactam in the treatment of meningitis: efficacy and meningeal diffusion].
Topics: Biological Assay; Cephalosporins; Cephamycins; Child; Child, Preschool; Humans; Infant; Meningitis; Moxalactam | 1983 |
Disulfiram-like reaction to certain cephalosporins.
Topics: Adolescent; Adult; Aged; Cefamandole; Cefoperazone; Cephalosporins; Cephamycins; Disulfiram; Drug Interactions; Ethanol; Female; Humans; Male; Moxalactam | 1983 |
[Treatment of septicemia with latamoxef. Multicentric study of 60 cases].
Topics: Adolescent; Adult; Aged; Blood Bactericidal Activity; Cephalosporins; Cephamycins; Female; Follow-Up Studies; Humans; Male; Middle Aged; Moxalactam; Sepsis | 1982 |
Moxalactam penetration of normal and osteomyelitic bone.
Topics: Animals; Bone and Bones; Capillary Permeability; Cephalosporins; Cephamycins; Disease Models, Animal; Dogs; Kinetics; Mathematics; Moxalactam; Osteomyelitis | 1983 |
Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Child; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Male; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin | 1983 |
Moxalactam kinetics during chronic ambulatory peritoneal dialysis.
Topics: Adult; Aged; Cephalosporins; Cephamycins; Female; Humans; Kidney Diseases; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Moxalactam; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory | 1983 |
[Haemophilus influenzae type b meningitis resistant to ampicillin and chloramphenicol treated with moxalactam].
Topics: Ampicillin; Cephalosporins; Cephamycins; Chloramphenicol; Haemophilus influenzae; Humans; Infant; Male; Meningitis, Haemophilus; Moxalactam; Penicillin Resistance | 1983 |
Enterococcal liver abscess associated with moxalactam therapy. Review of literature on enterococcal superinfections in association with moxalactam therapy.
Topics: Cephalosporins; Cephamycins; Humans; Liver Abscess; Male; Middle Aged; Moxalactam | 1983 |
Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Blood; Cefoxitin; Ceftazidime; Cephalosporins; Culture Media; Evaluation Studies as Topic; Humans; Imipenem; Moxalactam; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Sulfhydryl Compounds; Thienamycins; Urine | 1984 |
[Beta-lactams: present status and perspectives].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chemical Phenomena; Chemistry; Humans; Moxalactam; Penicillin Resistance; Penicillins; Terminology as Topic | 1984 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Staphylococcus; Streptococcus; Ticarcillin | 1980 |
In vitro efficacy of cefoperazone compared with cefotaxime, LY127935, and thienamycin.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Lactams; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Thienamycins | 1980 |
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Topics: Azlocillin; beta-Lactamases; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins | 1980 |
Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
Topics: Anaerobiosis; Bacteria; Bacteroides; Carbenicillin; Cefotaxime; Cephalosporins; Cephamycins; Clostridium; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1980 |
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Topics: Aerobiosis; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Fermentation; Microbial Sensitivity Tests; Moxalactam; Pseudomonas | 1980 |
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Topics: Aerobiosis; Bacteria; Blood; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Culture Media; Drug Resistance, Microbial; Humans; Moxalactam; Pseudomonas aeruginosa; Species Specificity; Staphylococcus aureus | 1980 |
In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
Topics: Ampicillin; Cefotaxime; Cephalosporins; Cephamycins; Haemophilus influenzae; Moxalactam; Penicillin Resistance; Species Specificity | 1980 |
Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels.
Topics: Adult; Blister; Body Fluids; Cefotaxime; Cephalosporins; Cephamycins; Escherichia coli; Humans; Kinetics; Male; Moxalactam | 1980 |
In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins.
Topics: Bacteria; Bacterial Infections; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Child; Drug Resistance, Microbial; Humans; Moxalactam | 1980 |
In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1980 |
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Topics: Aminoglycosides; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone.
Topics: Bacteria; Cefoperazone; Cefotaxime; Cephalosporinase; Cephalosporins; Cephamycins; Drug Interactions; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Moxalactam | 1981 |
Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
Topics: Ampicillin; Animals; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Escherichia coli; Humans; Kinetics; Listeria monocytogenes; Male; Meningitis; Moxalactam; Penicillin Resistance; Rabbits; Streptococcus agalactiae | 1981 |
Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
Topics: Ampicillin; Campylobacter; Campylobacter fetus; Cefoperazone; Cefotaxime; Cephalosporins; Cephalothin; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Streptomycin | 1981 |
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam | 1981 |
Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
Topics: Bacteria; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Moxalactam | 1981 |
Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
Topics: Ampicillin; Cefazolin; Cefotaxime; Cefotiam; Cefoxitin; Ceftriaxone; Cephalosporins; Cephalothin; Cephamycins; Female; France; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillins | 1981 |
Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Topics: Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftriaxone; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Neisseria meningitidis | 1981 |
In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
Topics: Ampicillin; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Time Factors | 1981 |
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Moxalactam | 1981 |
Comparative in-vitro activity of moxalactam and cefotaxime against isolates from blood culture.
Topics: Bacteria; Blood; Cefotaxime; Cephalosporins; Cephamycins; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis.
Topics: Animals; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Kinetics; Meningitis; Moxalactam; Rabbits; Sulfamethoxazole; Trimethoprim | 1981 |
Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Enterobacteriaceae Infections; Fermentation; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
New drugs for enteric gram-negative bacillary meningitis in adults.
Topics: Adult; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Meningitis; Meningitis, Haemophilus; Moxalactam | 1981 |
Potential value of cefoperazone in bacterial meningitis: experimental studies.
Topics: Animals; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Kinetics; Meningitis, Haemophilus; Moxalactam; Rabbits | 1981 |
Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
Topics: Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Ticarcillin | 1981 |
Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.
Topics: Ampicillin; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Humans; Moxalactam; Penicillin G; Penicillin Resistance; Streptococcal Infections; Streptococcus agalactiae | 1981 |
Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
Topics: beta-Lactamases; Carbenicillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa | 1981 |
Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
Topics: Bacteroides fragilis; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftizoxime; Cephalosporins; Cephamycins; In Vitro Techniques; Moxalactam | 1981 |
Comparative in vitro activity of first, second and third generation cephalosporins.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Structure-Activity Relationship | 1981 |
[Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
Topics: Bacteria; Cefazolin; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam | 1981 |
Resistance to cefamandole: a collaborative study of emerging clinical problems.
Topics: Adult; Aged; Bacteroides Infections; beta-Lactamases; Cefamandole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Isoelectric Focusing; Male; Middle Aged; Moxalactam; Penicillin Resistance; Penicillins | 1982 |
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens | 1981 |
The new cephalosporins and penicillins.
Topics: Azlocillin; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Mezlocillin; Moxalactam; Penicillins; Piperacillin | 1982 |
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin | 1982 |
Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
Topics: Animals; Cefoperazone; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Infusions, Parenteral; Kinetics; Male; Meningitis, Haemophilus; Meningitis, Pneumococcal; Moxalactam; Rabbits; Streptococcus pneumoniae | 1982 |
Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Synergism; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1982 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Culture Media; Humans; Injections, Intravenous; Moxalactam; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1981 |
Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 1981 |
In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.
Topics: Amdinocillin; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Drug Interactions; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Penicillin Resistance; Pseudomonas | 1982 |
Resistance of Listeria to cefotaxime and moxalactam.
Topics: Cefotaxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Listeriosis; Moxalactam | 1982 |
Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis.
Topics: Amdinocillin; Ampicillin; Animals; Cephalosporins; Cephamycins; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Kinetics; Male; Meningitis; Mice; Moxalactam; Penicillanic Acid; Rabbits | 1982 |
The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Listeria monocytogenes; Moxalactam; Yersinia | 1982 |
[Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
Topics: Bacteria; Cefazolin; Cefmenoxime; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Gentamicins; Moxalactam; Structure-Activity Relationship | 1982 |
[Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
Topics: Bacteria; Cefazolin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Moxalactam | 1982 |
Effects of moxalactam and cefotaxime on rabbit renal tissue.
Topics: Acetylglucosaminidase; Animals; Cefotaxime; Cephalosporins; Cephamycins; Creatine; Kidney; Kidney Glomerulus; Male; Moxalactam; Rabbits | 1982 |
In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Clostridium; Microbial Sensitivity Tests; Moxalactam | 1982 |
[Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Topics: Acinetobacter; Bacteria; Bacteroides fragilis; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Providencia; Pseudomonas aeruginosa | 1982 |
[Statistical regression analysis for four new cephalosporins (author's transl)].
Topics: Bacteria; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam; Regression Analysis | 1982 |
Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
Topics: Azlocillin; Cefotaxime; Cefsulodin; Cephalosporins; Cephamycins; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1982 |
[Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
Topics: Bacteria; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Gentamicins; Microbial Sensitivity Tests; Moxalactam | 1982 |
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1981 |
Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Humans; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1982 |
The newest cephalosporins: how to use them?
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Moxalactam | 1982 |
[Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Cefsulodin; Ceftizoxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens | 1982 |
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Topics: Acinetobacter; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Gentamicins; Imipenem; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia; Thienamycins | 1982 |
Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephalothin; Cephamycins; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam | 1982 |
Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans.
Topics: Adolescent; Adult; Aged; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Cephamycins; Humans; Kinetics; Middle Aged; Models, Biological; Moxalactam; Myelography; Protein Binding; Time Factors | 1982 |
In-vitro and in-vivo efficacy of ceftriaxone, moxalactam, and chloramphenicol against Haemophilus influenzae type b.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Chloramphenicol; Haemophilus Infections; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam; Rats | 1982 |
The in vitro activity of ceftazidime against resistant clinical isolates.
Topics: Bacteria; Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1983 |
[Clinical results of latamoxef on pertussis].
Topics: Bordetella pertussis; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Resistance, Microbial; Humans; Infant; Infusions, Parenteral; Male; Moxalactam; Whooping Cough | 1983 |
[The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Topics: Bacteria; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacter; Haemophilus influenzae; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Proteus; Streptococcus pneumoniae | 1983 |
Ceftriaxone--and more to come.
Topics: Bacterial Infections; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Child; Humans; Microbial Sensitivity Tests; Moxalactam | 1983 |
[In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Enterobacteriaceae; Moxalactam | 1983 |
Synthesis and biological properties of sodium (5R, 6S, 8R)-6 alpha-hydroxyethyl-2-carbamoyloxymethyl-2-penem-3-carboxylate (FCE 22101) and its orally absorbed esters FCE 22553 and FCE 22891.
Topics: Administration, Oral; Animals; Cefotaxime; Cephalosporins; Cephamycins; Indicators and Reagents; Injections, Intravenous; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Moxalactam; Structure-Activity Relationship | 1983 |
[Symposium on moxalactam: the French experience. Preclinical and therapeutic evaluation. Paris, 27 October 1981].
Topics: Cephalosporins; Cephamycins; Humans; Moxalactam | 1983 |
[Moxalactam: preclinical evaluation].
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Cephalosporins; Cephamycins; Enterobacteriaceae; Escherichia coli; Haemophilus; Microbial Sensitivity Tests; Moxalactam | 1983 |
[Moxalactam: a new group of beta-lactams].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Kinetics; Moxalactam; Structure-Activity Relationship | 1983 |
[In vitro action of moxalactam on hospital bacteria. Results of a multicenter survey].
Topics: Bacteria; Bacteroides fragilis; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Haemophilus; Humans; Microbial Sensitivity Tests; Moxalactam; Staphylococcus; Streptococcus | 1983 |
[In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
Topics: beta-Lactamases; Cefotaxime; Cephalosporinase; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Hydrolysis; Moxalactam | 1983 |
[Moxalactam: an inactivator of beta-lactamases].
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Kinetics; Moxalactam | 1983 |
[Pharmacokinetics of moxalactam in adults].
Topics: Adult; Cephalosporins; Cephamycins; Diffusion; Half-Life; Humans; Kidney; Kidney Failure, Chronic; Kinetics; Moxalactam; Renal Dialysis; Tissue Distribution | 1983 |
[Comparative pharmacokinetics of moxalactam and other cephalosporins].
Topics: Bile; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Half-Life; Humans; Injections, Intravenous; Kidney; Kinetics; Moxalactam; Tissue Distribution | 1983 |
[Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Kinetics; Male; Meningitis, Haemophilus; Moxalactam; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1983 |
[The French experience with moxalactam in pneumology].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bronchitis; Bronchopneumonia; Cephalosporins; Cephamycins; Female; France; Humans; Injections, Intramuscular; Male; Middle Aged; Moxalactam; Pneumonia; Respiratory Tract Infections | 1983 |
[Moxalactam in complications of abdominal surgery].
Topics: Abdomen; Adolescent; Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Humans; Middle Aged; Moxalactam; Peritonitis; Postoperative Complications | 1983 |
[Moxalactam. Bibliographic references].
Topics: Animals; Bibliographies as Topic; Cephalosporins; Cephamycins; Humans; Moxalactam | 1983 |
[In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
Topics: Anti-Bacterial Agents; Bacteria; Cefmenoxime; Cefotaxime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Moxalactam | 1983 |
[In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
Topics: Bacteria; Cefotaxime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Staphylococcus aureus | 1983 |
New beta-lactamase-resistant cephem treatment of guinea pigs infected with Legionella pneumophila.
Topics: Animals; Cefotaxime; Cefotiam; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Erythromycin; Guinea Pigs; Legionnaires' Disease; Moxalactam | 1983 |
[In-vitro activity of cefotaxime].
Topics: Cefotaxime; Cefoxitin; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Streptococcal Infections; Streptococcus | 1983 |
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1983 |
Entry of four cephalosporins into the ovine lung.
Topics: Albumins; Animals; Binding, Competitive; Blood Proteins; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Female; Humans; Lung; Lymph; Moxalactam; Proteins; Sheep | 1984 |
Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamases; Cefmetazole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam | 1984 |
[Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefotaxime; Cefotetan; Cefsulodin; Cephalosporins; Cephamycins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Kanamycin; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Sisomicin | 1983 |
A study of cefoxitin, moxalactam, and ceftazidime kinetics in pregnancy.
Topics: Adult; Amniotic Fluid; Cefoxitin; Ceftazidime; Cephalosporins; Female; Humans; Kinetics; Maternal Age; Maternal-Fetal Exchange; Moxalactam; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second | 1983 |
[Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
Topics: Cefazolin; Cefmetazole; Cephalexin; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Escherichia coli; Humans; Moxalactam; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 1984 |
Bleeding secondary to vitamin K deficiency in patients receiving parenteral cephem antibiotics.
Topics: Aged; Bacteria; Blood Coagulation Factors; Cefazolin; Cefmetazole; Cefoperazone; Ceftazidime; Cephalosporins; Cephamycins; Female; Hemorrhage; Humans; Injections, Intravenous; Intestines; Male; Moxalactam; Vitamin K; Vitamin K Deficiency | 1984 |
[Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1982). I. Susceptibility distribution].
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Cephalosporins; Enterococcus faecalis; Escherichia coli; Gentamicins; Humans; Klebsiella; Moxalactam; Penicillin Resistance; Penicillins; Pseudomonas; Staphylococcus; Urinary Tract Infections | 1984 |
[Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1982). III. Secular changes in susceptibility].
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Citrobacter; Escherichia coli; Humans; Klebsiella; Moxalactam; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Time Factors; Urinary Tract Infections | 1984 |
[A child case of Yersinia pseudotuberculosis septicemia].
Topics: Cephalosporins; Child, Preschool; Humans; Male; Moxalactam; Sepsis; Yersinia Infections; Yersinia pseudotuberculosis Infections | 1984 |
[Bacteriological investigations with a new Semisynthetic oxy-beta-lactam antibiotic LY 127935 (AUTHOR'S TRANSL)].
Topics: Bacteria; Cephalosporins; Cephalothin; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1980 |
Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis.
Topics: Aged; Blood-Brain Barrier; Cephalosporins; Cephamycins; Escherichia coli Infections; Humans; Injections, Intravenous; Klebsiella Infections; Male; Meningitis; Middle Aged; Moxalactam | 1980 |
Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers.
Topics: Adult; Cephalosporins; Cephamycins; Half-Life; Humans; Injections, Intramuscular; Injections, Intravenous; Kinetics; Male; Moxalactam; Time Factors | 1980 |
Treatment of experimental Haemophilus influenzae type b meningitis with 1-oxa-beta-lactam (LY127935).
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Haemophilus influenzae; Meningitis, Haemophilus; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Rats | 1980 |
Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Cefamandole; Cefoperazone; Cephalosporins; Cephalothin; Cephamycins; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1980 |
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefamandole; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Tobramycin | 1980 |
The pharmacokinetics of LY127935, a broad spectrum oxa-beta-lactam.
Topics: Adult; Blister; Cantharidin; Cephalosporins; Cephamycins; Exudates and Transudates; Half-Life; Humans; Kinetics; Male; Models, Biological; Moxalactam; Tissue Distribution | 1980 |
Therapy of obstetrical infections with moxalactam.
Topics: Abortion, Spontaneous; Bacteria; Cephalosporins; Cephamycins; Cesarean Section; Female; Humans; Microbial Sensitivity Tests; Moxalactam; Postoperative Complications; Pregnancy; Puerperal Infection | 1980 |
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
Topics: Amikacin; Ampicillin; Carbenicillin; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Clindamycin; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Haemophilus influenzae; Moxalactam; Oxacillin | 1980 |
In vitro antibacterial activity of moxalactam, a new broad-spectrum semisynthetic antibiotic.
Topics: Cefamandole; Cephalosporins; Cephamycins; Erysipelothrix; Escherichia coli; Gram-Negative Aerobic Bacteria; In Vitro Techniques; Klebsiella pneumoniae; Moxalactam; Proteus; Salmonella; Shigella; Staphylococcus; Streptococcus | 1980 |
[In vitro activity of the oxa-beta-lactam LY 127935 against Bacteroides fragilis and other anaerobic gram-negative rods (author's transl)].
Topics: Bacteroides; Bacteroides fragilis; Cephalosporins; Cephamycins; Moxalactam | 1980 |
The in vitro antibacterial activity of LY127935 (6059S), a novel 1-oxa-beta-lactam antibiotic.
Topics: Bacteroides; beta-Lactamases; Cephalosporins; Cephamycins; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam; Staphylococcus aureus; Streptococcaceae | 1980 |
Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation.
Topics: Animals; Bacteria; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Half-Life; Humans; Mice; Moxalactam; Species Specificity | 1980 |
Moxalactam (6059-S), a new 1-oxa-beta-lactam: binding affinity for penicillin-binding proteins of Escherichia coli K-12.
Topics: Bacterial Proteins; Binding, Competitive; Cell Membrane; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Escherichia coli; Membrane Proteins; Moxalactam; Penicillin G; Protein Binding | 1980 |
Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.
Topics: beta-Lactamases; Cefoperazone; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Haemophilus; Haemophilus influenzae; Humans; Moxalactam | 1980 |
Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis.
Topics: Ampicillin; Animals; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Disease Models, Animal; Gentamicins; Male; Meningitis; Moxalactam; Netilmicin; Rabbits; Species Specificity | 1980 |
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin | 1980 |
In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin.
Topics: Ampicillin; Cephalosporins; Cephamycins; Child; Chloramphenicol; Drug Synergism; Haemophilus influenzae; Humans; Moxalactam; Penicillin Resistance; Penicillins; Ticarcillin | 1980 |
The beta-lactamase stability of a novel beta-lactam antibiotic containing a 7 alpha-methoxyoxacephem nucleus.
Topics: Anti-Bacterial Agents; beta-Lactamases; Binding, Competitive; Cephalosporins; Cephamycins; Drug Stability; Hydrolysis; Moxalactam; Pseudomonas aeruginosa | 1980 |
In vitro evaluation of LY127935, a new beta-lactam antibiotic with broad-spectrum activity.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1980 |
Tentative interpretive standards for disk susceptibility tests with moxalactam (LY127935).
Topics: Cephalosporins; Cephalothin; Cephamycins; Humans; Microbial Sensitivity Tests; Moxalactam | 1980 |
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.
Topics: Bacterial Infections; Brain Abscess; Cephalosporins; Cephamycins; Escherichia coli Infections; Female; Half-Life; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infusions, Parenteral; Injections, Intramuscular; Kinetics; Klebsiella Infections; Male; Meningitis; Moxalactam; Salmonella Infections; Serratia marcescens | 1981 |
Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.
Topics: Blood-Brain Barrier; Cephalosporins; Cephamycins; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Infant; Kinetics; Meningitis, Haemophilus; Meningitis, Meningococcal; Meningitis, Pneumococcal; Moxalactam | 1981 |
1-Oxacephalosporins: enhancement of beta-lactam reactivity and antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporinase; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Microbial Sensitivity Tests; Moxalactam | 1981 |
Moxalactam for obstetric and gynecologic infections. In vitro and dose-finding studies.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Bacteroides; Cephalosporins; Cephamycins; Cesarean Section; Drug Evaluation; Enterobacteriaceae; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests; Moxalactam; Parametritis; Pelvic Inflammatory Disease; Postoperative Complications | 1981 |
Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Moxalactam; Pseudomonas Infections | 1981 |
Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction.
Topics: Adolescent; Adult; Cephalosporins; Cephamycins; Creatinine; Female; Humans; Kidney Diseases; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Moxalactam | 1980 |
Steady-state moxalactam kinetics: comparisons with other cephalosporins.
Topics: Adult; Aged; Cephalosporins; Cephamycins; Child; Creatinine; Female; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Pseudomonas aeruginosa | 1981 |
Effects of cefazolin and moxalactam on serum chemistry values determined by autoanalyzer.
Topics: Adult; Anti-Bacterial Agents; Autoanalysis; Blood Chemical Analysis; Cefazolin; Cephalosporins; Cephamycins; Creatinine; Female; Humans; Male; Moxalactam | 1981 |
Role of the 7 alpha-methoxy and side-chain carboxyl of moxalactam in beta-lactamase stability and antibacterial activity.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cephamycins; Drug Stability; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Proteus vulgaris; Structure-Activity Relationship | 1981 |
Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefamandole; Cephalosporins; Cephamycins; Chloramphenicol; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
Correlation of moxalactam (LY127935) susceptibility tests by disk diffusion and agar plate dilution methods.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1981 |
Pharmacokinetics of moxalactam in patients with renal insufficiency.
Topics: Cephalosporins; Cephamycins; Creatinine; Half-Life; Humans; Injections, Intramuscular; Kidney Diseases; Kinetics; Moxalactam | 1981 |
Moxalactam pharmacokinetics during hemodialysis.
Topics: Aged; Cephalosporins; Cephamycins; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Middle Aged; Moxalactam; Renal Dialysis | 1981 |
Clinical pharmacology of moxalactam in patients with malignant disease.
Topics: Adult; Aged; Biological Assay; Cephalosporins; Cephamycins; Escherichia coli; Humans; Injections, Intravenous; Kinetics; Middle Aged; Moxalactam; Neoplasms; Time Factors | 1981 |
Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiency.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Moxalactam; Osteomyelitis; Pseudomonas aeruginosa; Serratia marcescens; Skin Diseases, Infectious; Urinary Tract Infections | 1981 |
Antibiotic-associated colitis during moxalactam therapy.
Topics: Cephalosporins; Cephamycins; Clostridium Infections; Colitis; Female; Humans; Middle Aged; Moxalactam | 1981 |
[The penetration of moxalactam into bone (author's transl)].
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Computers; Female; Femur; Half-Life; Hip Prosthesis; Humans; Male; Moxalactam | 1981 |
Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
Topics: Bacteria; beta-Lactamases; Cefoperazone; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Microbial Sensitivity Tests; Moxalactam | 1981 |
Successful treatment of gram-negative bacillary meningitis with moxalactam.
Topics: Adult; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Middle Aged; Moxalactam | 1981 |
Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Metabolic Clearance Rate; Middle Aged; Moxalactam | 1981 |
Moxalactam in treatment of recurrent Escherichia coli meningitis and ventriculitis in an infant with agammaglobulinemia.
Topics: Agammaglobulinemia; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Cerebral Ventricles; Encephalitis; Escherichia coli Infections; Humans; Infant; Male; Meningitis; Moxalactam; Recurrence | 1981 |
Hypoprothrombinemia associated with moxalactam treatment of a septic sternoclavicular arthritis due to Citrobacter diversus.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cephalosporins; Cephamycins; Citrobacter; Enterobacteriaceae Infections; Humans; Hypoprothrombinemias; Male; Middle Aged; Moxalactam; Sternoclavicular Joint | 1981 |
Paradoxic and tolerant effects of moxalactam on Staphylococcus aureus.
Topics: Cephalosporins; Cephamycins; Drug Resistance, Microbial; Microbial Sensitivity Tests; Moxalactam; Staphylococcus aureus | 1981 |
Epimers of moxalactam: in vitro comparison of activity and stability.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Cephamycins; Drug Stability; Half-Life; Humans; Moxalactam; Species Specificity; Stereoisomerism | 1981 |
Biliary excretion of moxalactam.
Topics: Bile; Biological Assay; Cephalosporins; Cephamycins; Humans; Liver; Moxalactam | 1981 |
Determination of moxalactam in human body fluids by liquid chromatographic and microbiological methods.
Topics: Biological Assay; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Drug Stability; Humans; Moxalactam; Time Factors | 1981 |
Moxalactam kinetics in hemodialysis.
Topics: Adult; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Moxalactam; Renal Dialysis | 1981 |
Comparative activities of moxalactam (LY 127935) a new semisynthetic 1-oxa-beta lactam antibiotic with 7 other antibiotics against type b Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Cephalosporins; Cephamycins; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam | 1981 |
[Clinical results and pharmacokinetics of 6059-S in the field of pediatrics (author's transl)].
Topics: Age Factors; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Kinetics; Male; Moxalactam; Respiratory Tract Infections; Urinary Tract Infections | 1981 |
[Clinical studies on 6059-S in the field of pediatrics (author's transl)].
Topics: Acute Disease; Adolescent; Age Factors; Agranulocytosis; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Enteritis; Female; Humans; Infant; Male; Moxalactam; Respiratory Tract Infections; Suppuration; Urinary Tract Infections | 1981 |
[Clinical studies on 6059-S in pediatric field (author's transl)].
Topics: Age Factors; Bacterial Infections; Cephalosporins; Cephamycins; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Moxalactam | 1981 |
[Fundamental and clinical studies in pediatric field on 6059-S (author's transl)].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Parenteral; Injections, Intravenous; Male; Moxalactam | 1981 |
[Basic and clinical examinations of 6059-S in pediatrics (author's transl)].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Infant, Newborn; Male; Moxalactam | 1981 |
[Clinical evaluation of 6059-S in children, particularly in the treatment of bacterial meningitis (author's transl)].
Topics: Adolescent; Age Factors; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Moxalactam | 1981 |
[Clinical evaluation of 6059-S therapy in children (author's transl)].
Topics: Adolescent; Age Factors; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Injections, Intravenous; Male; Moxalactam | 1981 |
[Clinical studies of 6059-S in the field of pediatrics (author's transl)].
Topics: Age Factors; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Moxalactam | 1981 |
[Clinical studies on 6059-S for acute peritonitis. Clinical effect and tissue concentration (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Aged; Body Fluids; Cephalosporins; Cephamycins; Child; Drug Evaluation; Female; Humans; Male; Middle Aged; Moxalactam; Peritonitis; Tissue Distribution | 1981 |
[Clinical studies on 6059-S for biliary tract diseases. Clinical effect and tissue concentration (author's transl)].
Topics: Adult; Aged; Bile; Biliary Tract; Cephalosporins; Cephamycins; Cholangitis; Cholecystitis; Drug Evaluation; Female; Humans; Male; Middle Aged; Moxalactam | 1981 |
[Bacteriological and clinical studies of 6059-S in pediatric infections (author's transl)].
Topics: Adolescent; Age Factors; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Female; Haemophilus influenzae; Humans; Infant; Male; Moxalactam; Penicillin Resistance | 1981 |
[Clinical study on 6059-S in children (author's transl)].
Topics: Age Factors; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Moxalactam | 1981 |
[Experimental and clinical studies on 6059-S (author's transl)].
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Parenteral; Injections, Intravenous; Male; Moxalactam | 1981 |
[Laboratory and clinical studies on 6059-S in children (author's transl)].
Topics: Age Factors; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Moxalactam | 1981 |
[Laboratory and clinical studies of 6059-S in pediatric field (author's transl)].
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Injections, Intravenous; Male; Moxalactam | 1981 |
[S-6059 preparation].
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Drug Stability; Humans; Mice; Moxalactam; Rats | 1981 |
[Prospects in antibiotic treatment of internal diseases].
Topics: Aged; Brain Abscess; Cephalosporins; Cephamycins; Female; Humans; Liver Abscess; Male; Middle Aged; Moxalactam | 1981 |
Moxalactam therapy for a wide spectrum of bacterial infections in adults.
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Moxalactam; Pseudomonas aeruginosa; Staphylococcus; Staphylococcus aureus; Streptococcus | 1981 |
Therapy of lower respiratory tract infections with moxalactam.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Cefamandole; Cephalosporins; Cephalothin; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Moxalactam; Pneumonia; Species Specificity | 1981 |
Procedure for assay of tobramycin in serum containing moxalactam.
Topics: Anti-Bacterial Agents; Bacillus cereus; Bacillus subtilis; Biological Assay; Cephalosporinase; Cephalosporins; Cephamycins; Humans; Hydrolysis; Moxalactam; Tobramycin; Zinc | 1981 |
Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
Topics: Animals; Bacteria; beta-Lactamases; Cattle; Cell-Free System; Cephalosporinase; Cephalosporins; Cephamycins; Drug Stability; Hydrolysis; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam | 1981 |
High-performance liquid chromatographic analysis of a new beta-lactam antibiotic, 6059-S (moxalactam).
Topics: Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Humans; Microbiological Techniques; Moxalactam; Time Factors | 1981 |
Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy.
Topics: Adult; Bacterial Infections; Cephalosporins; Cephalothin; Cephamycins; Drug Resistance, Microbial; Female; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects.
Topics: Blood Proteins; Cephalosporins; Cephamycins; Humans; Kidney Failure, Chronic; Kinetics; Moxalactam; Protein Binding; Renal Dialysis; Time Factors; Tissue Distribution | 1981 |
Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.
Topics: Adult; Aged; Cephalosporins; Cephamycins; Enterobacteriaceae; Female; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Moxalactam; Renal Dialysis | 1981 |
Moxalactam therapy for bacterial infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Pseudomonas Infections; Sepsis; Structure-Activity Relationship | 1981 |
Effect of 6059-S, a noval oxacephem, on cross-linking reaction of peptidoglycan biosynthesis in Escherichia coli, Pseudomonas aeruginosa and Serratia marcescens.
Topics: Carbohydrate Conformation; Cephalosporins; Cephamycins; Escherichia coli; Moxalactam; Peptidoglycan; Pseudomonas aeruginosa; Serratia marcescens | 1981 |
Studies of moxalactam for gram-negative and Haemophilus influenzae meningitis: an appraisal.
Topics: Anti-Bacterial Agents; Cephalosporins; Cephamycins; Child; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Meningitis; Meningitis, Haemophilus; Moxalactam | 1981 |
Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis.
Topics: Anti-Bacterial Agents; Cephalosporins; Cephamycins; Child, Preschool; Haemophilus influenzae; Humans; Infant; Meningitis; Meningitis, Haemophilus; Meningitis, Pneumococcal; Moxalactam | 1981 |
Citrobacter meningitis and cerebral abscess in early infancy: cure by moxalactam.
Topics: Brain Abscess; Cephalosporins; Cephamycins; Citrobacter; Enterobacteriaceae Infections; Humans; Infant, Newborn; Male; Meningitis; Moxalactam | 1981 |
The pharmacokinetics of moxalactam in renal failure.
Topics: Cephalosporins; Cephamycins; Escherichia coli; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Microbial Sensitivity Tests; Moxalactam; Renal Dialysis; Stereoisomerism | 1981 |
The activity in vitro of ceftazidime (GR 20263) and moxalactam (LY 127935) against Gram-negative bacteria from hospital patients.
Topics: Bacteria; Ceftazidime; Cephalosporins; Cephamycins; Cross Infection; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
Measurement of serum and tissue concentration of moxalactam using high pressure liquid chromatography.
Topics: Biological Assay; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Humans; Moxalactam; Tissue Distribution | 1981 |
Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion.
Topics: Adult; Cefazolin; Cephalosporins; Cephamycins; Female; Half-Life; Humans; Infusions, Parenteral; Kinetics; Male; Moxalactam | 1981 |
Penetration of ocular tissues and fluids by moxalactam in rabbits with staphylococcal endophthalmitis.
Topics: Animals; Cephalosporins; Cephamycins; Conjunctiva; Endophthalmitis; Eye; Injections; Injections, Intramuscular; Moxalactam; Rabbits; Staphylococcal Infections | 1981 |
Penetration of moxalactam into its target proteins in Escherichia coli K-12: comparison of a highly moxalactam resistant mutant with its parent strain.
Topics: Bacterial Proteins; beta-Lactamases; Cell Membrane; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Escherichia coli; Moxalactam; Mutation; Protein Binding | 1981 |
In vitro activity, efficacy, and pharmacology of moxalactam, a new beta-lactam antibiotic.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Female; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam | 1981 |
Moxalactam disodium (Moxam).
Topics: Adult; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Costs and Cost Analysis; Humans; Infant, Newborn; Kinetics; Moxalactam | 1982 |
Moxalactam epimer kinetics in children.
Topics: Anti-Bacterial Agents; Cephalosporins; Cephamycins; Child, Preschool; Female; Humans; Infant; Kinetics; Male; Moxalactam; Stereoisomerism | 1982 |
Interaction of moxalactam and gentamicin: in-vitro study with strains of Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Cephalosporins; Cephamycins; Drug Interactions; Gentamicins; Humans; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 1982 |
In-vitro activity and beta-lactamase stability of Sch 29482, a penem antibiotic. Comparisons with ceftazidime and moxalactam.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Cephamycins; Culture Media; Drug Stability; Lactams; Microbial Sensitivity Tests; Moxalactam | 1982 |
Pharmacokinetics of moxalactam in patients with normal and impaired renal function.
Topics: Adult; Aged; Cephalosporins; Cephamycins; Creatinine; Female; Humans; Kidney Function Tests; Kinetics; Metabolic Clearance Rate; Middle Aged; Moxalactam; Nephritis | 1982 |
[Comparative nephrotoxicity of latamoxef and other cephalosporins in rabbits. Combined administration with furosemide or tobramycin. (author's transl)].
Topics: Animals; Anti-Bacterial Agents; Blood Chemical Analysis; Cephalosporins; Cephamycins; Drug Synergism; Furosemide; Kidney; Kidney Diseases; Liver; Male; Moxalactam; Organ Size; Rabbits; Tobramycin | 1981 |
Penetration of intravenous moxalactam into human aqueous humor.
Topics: Aged; Aqueous Humor; Cataract Extraction; Cephalosporins; Cephamycins; Female; Humans; Injections, Intravenous; Male; Middle Aged; Moxalactam; Permeability | 1982 |
Use of moxalactam for bacterial meningitis.
Topics: Bacterial Infections; Cephalosporins; Cephamycins; Child; Humans; Meningitis; Moxalactam | 1982 |
[Chronic toxicity study of latamoxef in beagle dog (author's transl)].
Topics: Animals; Body Weight; Cephalosporins; Cephamycins; Dogs; Eating; Electrocardiography; Female; Hematologic Tests; Kidney; Liver; Male; Microscopy, Electron; Moxalactam; Organ Size | 1982 |
Penetration of cephalosporins and corresponding 1-oxacephalosporins through the outer layer of Gram-negative bacteria and its contribution to antibacterial activity.
Topics: Absorption; Bacteria; Cell Membrane; Cephalosporins; Cephamycins; Escherichia coli; Hydrolysis; Lactams; Moxalactam; Proteus | 1982 |
Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.
Topics: Acute Kidney Injury; Adult; Aged; Blood Coagulation Disorders; Cephalosporins; Female; Humans; Hypoprothrombinemias; Kidney Failure, Chronic; Male; Middle Aged; Moxalactam; Peritoneal Dialysis; Prothrombin Time; Renal Dialysis | 1983 |
Meningitis.
Topics: Bacterial Infections; Cephalosporins; Humans; Meningitis; Moxalactam; Penicillins | 1984 |
[Modification of vancomycin nephrotoxicity by other antibiotics in rats].
Topics: Animals; Cefpirome; Cephalosporins; Drug Therapy, Combination; Kidney; Male; Moxalactam; Rats; Rats, Sprague-Dawley; Vancomycin | 1995 |
Protein carbonyl formation in blood plasma by cephalosporins.
Topics: Antioxidants; Ascorbic Acid; Blood Proteins; Cefotaxime; Cephalosporins; Chelating Agents; Cysteine; Glutathione; Humans; Metals; Moxalactam; Oxidation-Reduction | 1997 |
Inhibitory effects of antibiotics on platelet aggregation in vitro.
Topics: Adult; Anti-Bacterial Agents; Blood Platelets; Cefamandole; Cephalosporins; Collagen; Female; Humans; Male; Middle Aged; Moxalactam; Platelet Aggregation Inhibitors | 1997 |
Structural insights into the design of inhibitors for the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Apoenzymes; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Captopril; Cephalosporins; Enzyme Inhibitors; Escherichia coli; Hydrogen Bonding; Hydrogen-Ion Concentration; Indicators and Reagents; Inhibitory Concentration 50; Ligands; Models, Molecular; Molecular Structure; Moxalactam; Protein Binding; Protein Structure, Secondary; Stenotrophomonas maltophilia; Stereoisomerism; Substrate Specificity; Sulfates; Water; X-Ray Diffraction; Zinc | 2008 |
Susceptibility of ceftazidime and other cephalosporins to a range of beta-lactamases and their potential as inducing agents.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enzyme Induction; Microbial Sensitivity Tests; Moxalactam | 1981 |